S. 2840Bipartisan Primary Care and Health Workforce ActTo improve access to and the quality of primary health care, expand the health workforce, and for other purposes.
HR5568Bipartisan HSA Improvement Act of 2023To amend the Internal Revenue Code of 1986 to improve health savings accounts.
HR5687 HSA Modernization Act of 2023To amend the Internal Revenue Code of 1986 to modernize health savings accounts.
Consumer Health Insurance Protection Act- legislation to set limits on insurance company profits to match those private insurers can earn in
Medicare and Medicaid, institute new protections to ensure all patients are notified when doctors are dropped from the network and are protected if they rely on an inaccurate provider directory or have a plan discontinued while in an active course of treatment
HR 3305Black Maternal Health Momnibus ActTo end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
TBD/Not yet introducedCHW Access ActTo amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs.
H.R.5378 -Lower Costs, More Transparency"Legislation to codify and strengthen hospital price transparency and transpanrecy in coverage regulations; to expand site neutral payments for drug administration services, to require each off-campus outpatient department of a Medicare provider to obtain and include a national provider identifier on billings for claims for service; and to extend funding for Community Health Centers, the National Health Service Corps, and
Teaching Health Centers that Operate GME Programs.
"
H.R.3561PATIENT Act"Legislation to codify and strengthen hospital price transparency and transpanrecy in coverage regulations; to expand site neutral payments for drug administration services, to require each off-campus outpatient department of a Medicare provider to obtain and include a national provider identifier on billings for claims for service; and to extend funding for Community Health Centers, the National Health Service Corps, and
Teaching Health Centers that Operate GME Programs.
"
S.1869SITE Act- To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
H.R.3417 - Facilitating Accountability in Reimbursements Act (FAIR Act) To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Duration: January 1, 2008
to
June 30, 2014
General Issues: Health Issues , Medicare/Medicaid , Pharmacy , Family Issues/Abortion/Adoption , Medical/Disease Research/Clinical Labs , Budget/Appropriations , Labor Issues/Antitrust/Workplace , Firearms/Guns/Ammunition , Trade (Domestic & Foreign) , Immigration , Government Issues , Agriculture , Economics/Economic Development
Spending: about $952,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), House of Representatives,, U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 24.
Original Filing: 301577101.xml
Lobbying Issues
HR 5378Lower Costs, More Transparency Act- Legislation to codify and strengthen hospital price transparency and transparency in coverage rules; enact site neutral payments for drug administration services; enact honest billing reforms to ensure a unique NPI number is used when billing to Medicare or commercial insurers to ensure large hospital systems do not overcharge for the care they deliver in outpatient settings.
H.R. 3305 - Black Maternal HealthMomnibusActBlack maternal health, social determinants of health
H.R. 4771 CHIPP Act -Makes CHIP permanent
S. 423Easy Enrollment in Health Care Act- Simplifies process of enrolling in health insurance
S. 1031EACH Act of 2023- Ends Hyde Amendment to guarantee abortion coverage
S. 3503Value in Health Care Act- extends aAPM bonus through 2026 at 3.5%. Increases Medicare Payment fee schedule changes for physicians' services from 1.25% to 2.5% for CY2024.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Stop Unfair Medicaid Recoveries Act - Medicaid Estate Recovery Program
HR 6545Physician Fee Schedule Update and Improvements Act - Physician fee schedule under the Medicare program
S 3430Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 - mental health care workforce and services, prescription drug costs, and provisions under Medicare and Medicaid
HR 6780Medically Tailored Home-Delivered Meals Demonstration Pilot Actestablishing a nationwide pilot program through Medicare to provide seniors with diet-impacted diseases medically tailored meals
S.570Medicaid Dental Benefit Act of 2023 - To amend title XIX of the Social Security Act to improve coverage of dental and oral health services for adults under Medicaid, and for other purposes.
S. 3138StabilizeMedicaidandCHIPCoverage Act - Medicaid and Childrens Health Insurance Program enrollment
S. 3892Community Health Worker Access Act - Medicare reimbursement for CHWs, promotoras, and CHRs
S. 1165Reentry Act of 2023Expands access to health care for Medicaid-eligible individuals 30 days before their release from jail or prison
Agencies Lobbied
U.S. Senate
Lobbying Issues
s.150Affordable Prescriptions for Patients Act of 2023 - To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
S.79Interagency Patent Coordination and Improvement Act of 2023 - To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
S.113Prescription Pricing for the People Act of 2023To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
S.142Preserve Access to Affordable Generics and Biosimilars Act - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products
S.148Stop STALLING Act - To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 19.
Original Filing: 301531066.xml
Lobbying Issues
HR. 3226PREEMIE ActResearch and education programs for preemies
HR5568Bipartisan HSA Improvement Act of 2023To amend the Internal Revenue Code of 1986 to improve health savings accounts.
HR5687 HSA Modernization Act of 2023To amend the Internal Revenue Code of 1986 to modernize health savings accounts.
H.R.5378Lower Costs, More TransparencyLegislation to codify and strengthen hospital price transparency and transparency in coverage regulations; to expand site neutral payments for drug administration services, to require each off-campus outpatient department of a Medicare provider to obtain and include a national provider identifier on billings for claims for service; and to extend funding for Community Health Centers, the National Health Service Corps, and Teaching Health Centers that Operate GME Programs.
S.3548Health Care Prices Revealed and Information to Consumers Explained Transparency Act - Legislation to require hospitals to post a machine-readable file of negotiated rates and requiring the actual cash price and not allowing providers to offer a median of the discounted cash prices for a service.
CHW Access Act Legislation to invest in community-based workforce and community health workers
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3305Black Maternal Health Momnibus ActTo end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
HR 5434Stabilize Medicaid and CHIP Coverage Act Continuous eligibility in Medicaid for adults
S.1869SITE ActTo amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
s.150Affordable Prescriptions for Patients Act of 2023To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
S.79Interagency Patent Coordination and Improvement Act of 2023To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
S.113Prescription Pricing for the People Act of 2023To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
S.142Preserve Access to Affordable Generics and Biosimilars ActTo prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products
S.148Stop STALLING ActTo enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
Families USA Foundation, Inc. amended a lobbying report for in-house lobbying in Q32023 on April 26
Original Filing: 301577371.xml
Lobbying Issues
S. 2840Bipartisan Primary Care and Health Workforce ActTo improve access to and the quality of primary health care, expand the health workforce, and for other purposes.
HR5568Bipartisan HSA Improvement Act of 2023To amend the Internal Revenue Code of 1986 to improve health savings accounts.
HR5687 HSA Modernization Act of 2023To amend the Internal Revenue Code of 1986 to modernize health savings accounts.
Consumer Health Insurance Protection Act- legislation to set limits on insurance company profits to match those private insurers can earn in
Medicare and Medicaid, institute new protections to ensure all patients are notified when doctors are dropped from the network and are protected if they rely on an inaccurate provider directory or have a plan discontinued while in an active course of treatment
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3305Black Maternal Health Momnibus ActTo end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
TBD/Not yet introducedCHW Access ActTo amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs.
H.R.5378 -Lower Costs, More Transparency"Legislation to codify and strengthen hospital price transparency and transpanrecy in coverage regulations; to expand site neutral payments for drug administration services, to require each off-campus outpatient department of a Medicare provider to obtain and include a national provider identifier on billings for claims for service; and to extend funding for Community Health Centers, the National Health Service Corps, and
Teaching Health Centers that Operate GME Programs.
"
H.R.3561PATIENT Act"Legislation to codify and strengthen hospital price transparency and transpanrecy in coverage regulations; to expand site neutral payments for drug administration services, to require each off-campus outpatient department of a Medicare provider to obtain and include a national provider identifier on billings for claims for service; and to extend funding for Community Health Centers, the National Health Service Corps, and
Teaching Health Centers that Operate GME Programs.
"
S.1869SITE Act- To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
H.R.3417 - Facilitating Accountability in Reimbursements Act (FAIR Act) To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301512282.xml
Lobbying Issues
S. 2840Bipartisan Primary Care and Health Workforce ActTo improve access to and the quality of primary health care, expand the health workforce, and for other purposes.
HR5568Bipartisan HSA Improvement Act of 2023To amend the Internal Revenue Code of 1986 to improve health savings accounts.
HR5687 HSA Modernization Act of 2023To amend the Internal Revenue Code of 1986 to modernize health savings accounts.
Consumer Health Insurance Protection Act- legislation to set limits on insurance company profits to match those private insurers can earn in
Medicare and Medicaid, institute new protections to ensure all patients are notified when doctors are dropped from the network and are protected if they rely on an inaccurate provider directory or have a plan discontinued while in an active course of treatment
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3305Black Maternal Health Momnibus ActTo end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
TBD/Not yet introducedCHW Access ActTo amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs.
H.R.5378 -Lower Costs, More Transparency"Legislation to codify and strengthen hospital price transparency and transpanrecy in coverage regulations; to expand site neutral payments for drug administration services, to require each off-campus outpatient department of a Medicare provider to obtain and include a national provider identifier on billings for claims for service; and to extend funding for Community Health Centers, the National Health Service Corps, and
Teaching Health Centers that Operate GME Programs.
"
H.R.3561PATIENT Act"Legislation to codify and strengthen hospital price transparency and transpanrecy in coverage regulations; to expand site neutral payments for drug administration services, to require each off-campus outpatient department of a Medicare provider to obtain and include a national provider identifier on billings for claims for service; and to extend funding for Community Health Centers, the National Health Service Corps, and
Teaching Health Centers that Operate GME Programs.
"
S.1869SITE Act- To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
H.R.3417 - Facilitating Accountability in Reimbursements Act (FAIR Act) To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301491881.xml
Lobbying Issues
HR 3417Facilitating Accountability in Reimbursements (FAIR) Act legislation would separate NPIs for off-campus HOPDs; Off-campus OPDs are considered subparts of a provider; Services rendered must be billed to this NPI; HHS may conduct compliance reviews of the requirements made law by this bill
HR2856Combatting Hospital Monopolies ActLegislation that fixes FTC oversight jurisdiction loophole to include nonprofit hospitals
S1451Healthy Competition for Better Care ActLegislation to ban anticompetitive contracting clauses between providers and insurers
TBD/Not yet introducedCHW Access ActTo amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs.
TBDASSIST Act this legislation would establish a new grant program at HHS to hire and retain mental health providers in schools and includes a 90% increase in federal matching funds to pay for those services.
S. 423Easy Enrollment in Health Care Act This bill revises the procedures related toenrollmentin health insurance affordability programs, including Medicaid, the Children's Health Insurance Program (CHIP), and state-operated Basic Health Programs. The bill provides funding to support the changes.
HR 824Telehealth Benefit Expansion for Workers Act of 2023To amend title XXVII of the Public Health Service Act, the Employee Retirement Income and Security Act of 1974, and the Internal Revenue Code of 1986 to treat benefits for telehealth services offered under a group health plan or group health insurance coverage as excepted benefit
HR 2813Self-Insurance Protection Act To amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to exclude from the definition of health insurance coverage certain medical stop-loss insurance obtained by certain plan sponsors of group health plans, and for other purposes.
HR 2868Association Health Plans ActTo amend the Employee Retirement Income Security Act of 1974 to clarify the treatment of certain association health plans as employers, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3305Black Maternal Health Momnibus ActTo end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
HR 3561PATIENT Act"-Codifies the Hospital Price Transparency Rule by amending statutory basis for the rule to explicitly require disclosure of negotiated rates in dollar amounts.
-Increases the maximum penalty for noncompliance to $5 million per year, allows HHS to further increase penalties after 2025.
-Eliminates the price estimator loophole in 2025.
-Directs HHS to implement a uniform method and format for hospitals to post data.
-Directs HHS to regularly monitor hospital compliance and publicly report on warning letters, corrective action plans, and fines.
-Codifies the Transparency in Coverage rule; Starting 2024 - health provider entities must submit annually to HHS the following: Data on mergers/acquisitions, business structure of any parent companies
If the entity is or includes a hospital, it must also report: Average debt-to-earnings ratio, average amount of debt incurred, real estate leases and purchases, and capital gains investments (if non-profit)
- Starting 2025 - HHS will post online a report on this information, and audit/punish those who fail to report. Starting 2024 - health provider entities must submit annually to HHS the following: Data on mergers/acquisitions, business structure of any parent companies
If the entity is or includes a hospital, it must also report: Average debt-to-earnings ratio, average amount of debt incurred, real estate leases and purchases, and capital gains investments (if non-profit)
- Starting 2024 with 4 year phase-in - Drug administration OPD services furnished off-campus will be subject to ASC rates rather than OPPS rates.
HHS will not take into account any resulting reduction in expenditures for budget neutrality adjustments Starting 2024 with 4 year phase-in - Drug administration OPD services furnished off-campus will be subject to ASC rates rather than OPPS rates.
"
S 1869Site-based invoicing and Transparency Enhancement (SITE) ACTLegislation expanding site neutral payments and preventing dishonest billing
Legislation implementing site-neutral payment policies across the board as recommended by MedPACxix, and to eliminate site-dependent reimbursement distortions that indirectly incentivize acquisition of non-hospital patient access points
R2863Preventing Hospital Overbilling of Medicare Act Legislation that - Redefines off-campus oupatient department of a provider to refer to only those departments not located on or within the distance of a hospital facility.; Removes site-neutral exception for off-campus emergency departments; Clarifies secretarial authority to promote site-neutral payments; Also ensures separate NPIs for off-campus outpatient departments of a provider; Requires off-campus departments of providers to charge for services using the separately established NPI
TBD/Not yet introducedAdvancing Maternal Health Equity Under Medicaid Act This bill provides a 90% federal matching rate forMedicaidmaternalhealthcare expenditures that exceed 2021 levels. Qualifying services must be provided by maternity care providers or perinatalhealthworkers (e.g., doulas) and include prenatal and postpartum telehealthservices, home visits, and behavioralhealthcare.
H.R. 561The Equal Access to Abortion Coverage in Health Insurance Act of 223To require federal health care programs to provide coverage for abortion services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2679The PBM Accountability ActTo amend the Public Health Service Act, the Employee Retirement Income Security Act, and the Internal Revenue Code of 1984 to increase oversight of pharmacy benefits manager services, and for other purposes
S. 1067Ensuring Timely Access to Generics Act of 2023To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
S. 1114Expanding Access to Low-Cost Generics Act of 2023To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period.
S. 1339Pharmacy Benefit Manager Reform Act To provide for increased oversight of entitiesthat provide pharmacy benefit managementserviceson behalf of group health plansand health insurance coverage.
S. 954Affordable Insulin Now Act of 2013To provide for appropriate cost-sharing forinsulinproducts covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discountedinsulinproducts to uninsured individuals.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 19, 2023.
Original Filing: 301457562.xml
Lobbying Issues
Legislation to ban anticompetitive contracting clauses between providers and insurers and in clinician and health care worker employment arrangements.
HR1692Health Care Affordability ActTo amend the Internal Revenue Code of 1986 to improve affordability and reduce premium costs of health insurance for consumers.
S. 346Black Maternal Health Momnibus Act of 2021/Momnibus 2.0 (pending)This bill directs multi-agency efforts to improve maternal health, particularly among racial and ethnic minority groups, veterans, and other vulnerable populations. It also addresses maternal health issues related to COVID-19 (i.e., coronavirus disease 2019).
H.R. 289Black Maternal Health Week Resolution Recognizing the designation of theweekof April 11 through April 17, 2023, as the sixth annual "BlackMaternalHealthWeek" to bring national attention to thematernalhealthcrisis in the United States and the importance of reducingmaternalmortality and morbidity amongBlackwomen and birthing persons.
H.R. 6164Perinatal Workforce Act of 2020This bill establishes grants for eligible education programs to grow and diversifythe perinatal workforce with respect to nurses, physician assistants, and other specified health workers, and otherwise addresses issues related to the maternal health workforce and care delivery models.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Stop the Waitdirects the Social Security Administration to phase out the 5-month waiting period to receive SSDI benefits and allow anyone who is uninsured or unable to afford insurance during the Medicare waiting period to receive Medicare coverage.
Legislation to strengthen and codify the hospital price transparency rule
Legislation implementing site-neutral payment policies across the board as recommended by MedPAC, and to eliminate site-dependent reimbursement distortions that indirectly incentivize acquisition of non-hospital patient access points
S.842/HR33 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023To amend titles XVIII and XIX of the Social Security Act to provide for coverage of dental and oral health services, vision services, and hearing services under the Medicare and Medicaid programs.
S.109Ensuring Kids Have Access to Medically Necessary Dental Care ActTo amend title XXI of the Social Security Act to prohibit lifetime or annual limits on dental coverage under the Children's Health Insurance Program, and to require wraparound coverage of dental services for certain children under such program.
H.R485Protecting Health Care for All Patients Act of 2023To amend title XI of the Social Security Act to prohibit the use of quality adjusted life years and similar measures in coverage and payment determinations under Federal health care programs.
H.R.1342/S570Medicaid Dental Benefit Act of 2023To amend title XIX of the Social Security Act to improve coverage of dental and oral health services for adults under Medicaid, and for other purposes.
CHW Access ActLegislation to ensure that community health workers have access to a sustinable payment model
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.113Prescription Pricing for the People Act of 2023To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
s.150Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1031/H.R. 561EACH Act of 2023To ensure affordable abortion coverage and care for every person, and for other purposes.
Agencies Lobbied
U.S. Senate
Type of Issue
Family Issues/Abortion/Adoption
4th Quarter, 2022
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301438962.xml
Lobbying Issues
S.3139Healthy Competition for Better Care Actban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.
H.R. 959/ S.346Black Maternal Health Momnibus Act of 2021This bill directs multi-agency efforts to improve maternal health, particularly among racial and ethnic minority groups, veterans, and other vulnerable populations. It also addresses maternal health issues related to COVID-19 (i.e., coronavirus disease 2019).
S. 3479Building a Sustainable Workforce for Health Communities ActThis bill reauthorizes through FY2027 and revises a program carried out by the Centers for Disease Control and Prevention that supports the use ofcommunityhealthworkersto improvehealthoutcomes in medically underserved communities.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 285/H.R.955Medicaid Reentry Act This bill allowsMedicaidpayment for medical services furnishedto anincarcerated individualduring the 30-day period preceding the individual's release. TheMedicaidand Children's Health Insurance Program (CHIP) Payment and Access Commission must report on specified information relating to the accessibility and quality of health care for incarcerated individuals, including the impactof the bill's changes.
S.411/H.R. 3047Momma's ActThis bill establishes various programs and requirements to reduce maternal mortality. It also increases federal tobacco taxes and equalizes the tax treatment of different tobacco products.
H.R. 1791CHIPP Act This bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
S. 646/H.R. 1738Stabilize Medicaid and CHIP Coverage ActThis bill requires the Children's Health Insurance Program (CHIP) and state Medicaid programs toprovide 12-monthcontinuousenrollment foreligible individuals.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301417816.xml
Lobbying Issues
Legislation to make permanent the APTC subsidies passed in American Rescue Plan
S.3139Healthy Competition for Better Care Actban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.
H.R. 959/ S.346Black Maternal Health Momnibus Act of 2021This bill directs multi-agency efforts to improve maternal health, particularly among racial and ethnic minority groups, veterans, and other vulnerable populations. It also addresses maternal health issues related to COVID-19 (i.e., coronavirus disease 2019).
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) ActA bill to reduce the cost of insulin
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
Legislation to minimize coverage losses in Medicaid and CHIP when redeterminations begin at the end of the Public Health Emergency
Capping Drug Costs for Seniors ActA bill to amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.
S. 285/H.R.955Medicaid Reentry Act This bill allowsMedicaidpayment for medical services furnishedto anincarcerated individualduring the 30-day period preceding the individual's release. TheMedicaidand Children's Health Insurance Program (CHIP) Payment and Access Commission must report on specified information relating to the accessibility and quality of health care for incarcerated individuals, including the impactof the bill's changes.
To amend Title VII of the Civil Rights Act of 1964 to require employers to provide to health plan enrollees expanded health insurance benefits for pregnancy, childbirth, and related medical conditions
KIDS Health Actwould support states in testing payment and delivery reforms that integrate SDOH approaches into health care for children and youth eligible for Medicaid and CHIP.
S.411/H.R. 3047Momma's ActThis bill establishes various programs and requirements to reduce maternal mortality. It also increases federal tobacco taxes and equalizes the tax treatment of different tobacco products.
H.R. 1791CHIPP Act This bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
S. 1512CONNECT for Health Act of 2021This bill expands coverage oftelehealthservices under Medicare.
S. 646/H.R. 1738 Stabilize Medicaid and CHIP Coverage ActThis bill requires the Children's Health Insurance Program (CHIP) and state Medicaid programs toprovide 12-monthcontinuousenrollment foreligible individuals.
H.R.5376 Inflation Reduction ActTo provide for reconciliation pursuant to title II of S. Con. Res. 14.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301389894.xml
Lobbying Issues
S201Improving Access to Health Care in Rural and Underserved Areas Actestablish a program ensuring access to accredited continuing medical education for primary care physicians and other health care providers at Federally-qualified health centers and rural health clinics, to provide training and clinical support for primary care providers to practice at their full scope and improve access to care for patients in underserved area
Legislation to make permanent the APTC subsidies passed in American Rescue Plan
S.201Improving Access to Health Care in Rural and Underserved Areas Act
S.3796/H.R.7045Closing Health Coverage Gaps for Public Servants ActTo eliminate the opt-out for nonfederal governmental health plans.
H.Con.Res.89Expressing opposition to the criminalization of essential health care, including the full range of sexual and reproductive health care such as abortion, gender-affirming care, and contraceptive care, and disapproving of the criminalization of pregnancy outcomes.
S.3139Healthy Competition for Better Care Actban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.
S.912/H.R. 1978Helping Adults Protect Immunity Act This bill requires state Medicaid programs to cover, without cost-sharing, vaccines foradultsthat are recommended by the Advisory Committee on Immunization Practices.
S.3799Prevent Pandemics ActThis bill sets out programs andactivities primarily to address public health preparedness and response.
H.R. 959/ S.346Black Maternal Health Momnibus Act of 2021This bill directs multi-agency efforts to improve maternal health, particularly among racial and ethnic minority groups, veterans, and other vulnerable populations. It also addresses maternal health issues related to COVID-19 (i.e., coronavirus disease 2019).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
Legislation to minimize coverage losses in Medicaid and CHIP when redeterminations begin at the end of the Public Health Emergency
Capping Drug Costs for Seniors ActA bill to amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.
S. 285/H.R.955Medicaid Reentry Act This bill allowsMedicaidpayment for medical services furnishedto anincarcerated individualduring the 30-day period preceding the individual's release. TheMedicaidand Children's Health Insurance Program (CHIP) Payment and Access Commission must report on specified information relating to the accessibility and quality of health care for incarcerated individuals, including the impactof the bill's changes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.7472Discounted Drugs for Clinical Trials Act To amend the Federal Food, Drug, and Cosmetic Act to grant eligible researchers access to eligible products at a discounted price for qualified research, and for other purposes.
H.R.7474Pharmaceutical Research and Transparency Act of 2022 To amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
H.R.7473Generic Substitution Non-Interference Act To prohibit pharmaceutical manufacturers from interfering with therapeutically equivalent or interchangeable substitution decisions by health care providers to limit competition from a generic drug or biosimilar biological product, and for other purposes.
H.R.7828Price Relief, Innovation, and Competition for Essential Drugs (PRICED) Act To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
legislation to fund grants for states to build and strengthen all payer claims databases
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 14, 2022.
Original Filing: 301356229.xml
Lobbying Issues
Build Back Better Act
Legislation to make permanent the APTC subsidies passed in American Rescue Plan
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
Legislation to amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for maternal health care services
CHIP Permanency ActThis bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
S.3796Closing Health Coverage Gaps for Public Servants ActTo eliminate the opt-outfornonfederal governmentalhealthplans.
S.3799Prevent Pandemics ActTo prepare for, and respond to, existing viruses, emerging new threats, andpandemics.
Legislation to make permanent the APTC subsidies passed in American Rescue Plan
S.3479Building a Sustainable Workforce for Healthy Communities ActTo amend the Public Health Service Act with respect to awards to support community health workers and community health.
S. 346Black Maternal Health Momnibus Act of 2021This bill directs multi-agency efforts to improve maternal health, particularly among racial and ethnic minority groups, veterans, and other vulnerable populations. It also addresses maternal health issues related to COVID-19 (i.e., coronavirus disease 2019).
S. 3139Healthy Competition for Better Care ActLegislation to ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 6698Stop Unfair Medicaid Recoveries ActTo amend title XIX of the Social Security Act to repeal the requirement that States establish a Medicaid Estate Recovery Program and to limit the circumstances in which a State may place a lien on a Medicaid beneficiarys property.
S 3700Affordable Insulin Now ActTo provide for appropriate cost-sharing forinsulinproducts covered under Medicare part D and private health plans
S.4011Capping Drug Costs for Seniors ActA bill to amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
H.R. 6612Advancing Maternal Health Equity Under Medicaid ActTo amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for maternal health care services.
Legislation to minimize coverage losses in Medicaid and CHIP when redeterminations begin at the end of the Public Health Emergency
HR6583Stop the Wait Act of 2022legislation to eliminate 5 month waiting period to receive SSDI and the 2 year waiting period for SSDI recipients to access Medicare coverage
H.R. 1791Children's Health Insurance Program Permanency Act This bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to require the Standard Occupational Classification System (OMB/BLS) to collect data on the doula workforce
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
S.1644Promising Pathway ActTo amend the Federal Food, Drug, and CosmeticActto establish a time-limited provisional approvalpathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2022.
Original Filing: 301329253.xml
Lobbying Issues
Build Back Better Act
Legislation to make permanent the APTC subsidies passed in American Rescue Plan
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
Legislation to amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for maternal health care services
HEAL for Immigrant Families Act of 2021This bill extends Medicaid and Children'sHealth Insurance Program coverage to individuals lawfully present in the United States who otherwise meet eligibility requirements. Individuals granted federally authorized presence also are required to maintain minimum essentialhealth insurance coverage and are eligible forhealth insurance exchanges, reduced cost sharing, premium subsidies, and premium tax credits.
COVID-19 Safe Birthing ActThis bill expands coverage of maternal health care under Medicare, Medicaid, the Children's Health Insurance Program (CHIP), and private health insurance.
CHIP Permanency ActThis bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
Legislation to create autoenrollment in ACA Marketplace
Agencies Lobbied
U.S. Senate
Lobbying Issues
Capping Prescription Costs Act To amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.
Build Back Better Act
Legislation to add a dental, vision, hearing benefit to Medicare
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
Legislation to amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for maternal health care services
HEAL for Immigrant Families Act of 2021This bill extends Medicaid and Children'sHealth Insurance Program coverage to individuals lawfully present in the United States who otherwise meet eligibility requirements. Individuals granted federally authorized presence also are required to maintain minimum essentialhealth insurance coverage and are eligible forhealth insurance exchanges, reduced cost sharing, premium subsidies, and premium tax credits.
COVID-19 Safe Birthing ActThis bill expands coverage of maternal health care under Medicare, Medicaid, the Children's Health Insurance Program (CHIP), and private health insurance.
CHIP Permanency ActThis bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
Lift the Bar Act of 2021To amend the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 to provide certain benefits to noncitizens, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to provide funding for the Department of Health and Human Services - funding for Consumer Assistance Programs (CAPs)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2021.
Original Filing: 301312846.xml
Lobbying Issues
Halt Obesity ActTo amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes.
Capping Prescription Costs Act To amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.
Legislation to create autoenrollment in ACA Marketplace
Build Back Better Act
Legislation to make permanent the APTC subsidies passed in American Rescue Plan
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
Legislation to amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for maternal health care services
HEAL for Immigrant Families Act of 2021This bill extends Medicaid and Children'sHealth Insurance Program coverage to individuals lawfully present in the United States who otherwise meet eligibility requirements. Individuals granted federally authorized presence also are required to maintain minimum essentialhealth insurance coverage and are eligible forhealth insurance exchanges, reduced cost sharing, premium subsidies, and premium tax credits.
COVID-19 Safe Birthing ActThis bill expands coverage of maternal health care under Medicare, Medicaid, the Children's Health Insurance Program (CHIP), and private health insurance.
CHIP Permanency ActThis bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Capping Prescription Costs Act To amend title XVIII of the Social Security Act to provide for a cap on beneficiary liability under part D of the Medicare program, and for other purposes.
Build Back Better Act
Legislation to add a dental, vision, hearing benefit to Medicare
Legislation to grant Medicare power to negotiate prescription drug prices, and address other causes for high costs of prescription drugs
Legislation to create federal solution for states that have not yet expanded Medicaid
Legislation to amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for maternal health care services
HEAL for Immigrant Families Act of 2021This bill extends Medicaid and Children'sHealth Insurance Program coverage to individuals lawfully present in the United States who otherwise meet eligibility requirements. Individuals granted federally authorized presence also are required to maintain minimum essentialhealth insurance coverage and are eligible forhealth insurance exchanges, reduced cost sharing, premium subsidies, and premium tax credits.
COVID-19 Safe Birthing ActThis bill expands coverage of maternal health care under Medicare, Medicaid, the Children's Health Insurance Program (CHIP), and private health insurance.
CHIP Permanency ActThis bill permanently extends the Children's Health Insurance Program (CHIP) and related measures, programs, and authorities.
Lift the Bar Act of 2021To amend the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 to provide certain benefits to noncitizens, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to provide funding for the Department of Health and Human Services - funding for Consumer Assistance Programs (CAPs)
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 19, 2021.
Original Filing: 301280798.xml
Lobbying Issues
Comprehensive Addiction Resources Emergency (CARE) Actestablishes various programs to address substance use disorder and opioid addiction, including grants for treatment, recovery, and harm reduction services as well as a program to distribute overdose reversal drugs.
HR2484Lowest Price for Patients ActTo amend title XXVII of the Public Health ServiceActand title XVIII of the Social SecurityActto require pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug, andforother purposes.
S1323End Price Gouging for Medications Act To require the Secretary of Health and Human Services to establish referencepricesforprescription drugsforpurposes of Federal health programs, andforother purposes.
We PAID Actlegislation that limits the price of certain prescription drugs that rely on patents developed with federal suppor
Child Suicide Prevention and Lethal Means Safety Act Legislation to address veteran safety and suicide prevention
Health Enterprise Zones Act of 2021To provide for the designation of areas as Health Enterprise Zones to reduce health disparities and improve health outcomes in such areas, and for other purposes.
S499Improving Health Insurance Affordability ActTo amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan, to improve cost-sharing subsidies under the Patient Protection and Affordable Care Act, and for other purposes.
Legislation to create auto-enrollment for marketplace insurance
HR3149/S1660HEAL for Immigrant Families Act of 2021To expand access tohealth care servicesforimmigrants by removing legal and policy barriers tohealth insurance coverage, andforother purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.151/HR525HCBS Access ActTo provide for an emergency increase in Federal funding to State Medicaid programs for expenditures on home and community-based services.
HR66Comprehensive Access to Robust Insurance Now Guaranteed (CARING) for Kids ActToamend title XXI of the Social SecurityActtopermanently extend the Childrens HealthInsuranceProgram, andforother purposes.
HR3Elijah Cummings Lower Drug Costs Now ActTo establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes.
HR955/S285Medicaid Re-Entry ActTo amend title XIX of the Social Security Act to allow States to make medical assistance available to inmates during the 30-day period preceding their release.
Legislation to lift the five-year bar for legally present immigrants to access Medicaid
HR4439Medicaid Dental Benefit ActTo amend title XIX of the Social Security Act to improve coverage of adult oral health care under the Medicaid program, and for other purposes.
HR4311Medicare Dental, Hearing and Vision Benefit ActTo amend title XVIII of the Social Security Act to provide for coverage of dental, vision, and hearing care under the Medicare program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to provide funding for the Department of Health and Human Services - funding for Consumer Assistance Programs (CAPs)
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301261689.xml
Lobbying Issues
S.220Emergency Family Stabilization Act - To provideemergencyrelief to youth, children, and families experiencing homelessness, in light of the health and economic consequences of COVID-19.
No Surprise Bills for New Moms Act
S.779the Protecting Americans with Preexisting Conditions Act of 2021 - To provide that certain rules and guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect.
S.263Worker Health Coverage Protection Act To preservehealthbenefits forworkers
HR369Health Care Affordability Act- To amend the Internal Revenue Code of 1986 to improveaffordabilityand reduce premium costs ofhealthinsurance for consumers.
HR526Ensuring Coverage in Public Health Emergencies Act -To provide for special enrollment periods duringpublichealthemergencies.
S.104/HR379Improving Social Determinants of Health Act- To authorize the Directorofthe Centers for Disease Control and Prevention to carry out aSocialDeterminantsofHealthProgram, and for other purposes.
S.346/HR959Black Maternal Health Momnibus-To end preventable maternal mortality and severe maternal morbidity in the United States and close disparities in maternal health outcomes, and for other purposes.
S.1002Junk Plan Accountability and Disclosure Act - prohibit false or misleading advertising for health insurance coverage, require warnings and reporting with respect to noncomprehensive health plans, encourage enrollment in health plans, and for other purposes.
Legislation to expand the role of and support community health workers
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.245SAME Act of 2021.- provide thesamelevelofFederal matching assistance for every State that chooses to expand Medicaid coverage to newly eligible individuals, regardlessofwhen such expansion takes place, and for other purposes.
HR918/S.274Stronger Medicaid Response to the COVID-19 Pandemic Act- allow Statestoprovide coverage undertheMedicaidprogram for vaccines and treatment for COVID-19 for uninsured individuals withouttheimposition of cost sharing requirements, and for other purposes.
S.97/HR502Medicare Dental Benefit Act of 2021 - provide for coverage of dental services under the Medicare program.
S.560Oral Health for Moms Act - improve coverage of maternal oral health care, and for other purposes.
HR1025Kids Access to Primary Care - renew the application of the Medicarepayment rate floortoprimarycareservices furnished under the Medicaid program, and for other purposes.
S411/HR1897Mothers and Offspring Mortality and Morbidity Awareness (MOMMA) Act - improve Federal efforts with respect to the prevention of maternalmortality,andfor other purposes.
S.439/HR1353Coronavirus Medicaid Response Act - increase Federal support to StateMedicaidprograms during economic downturns, and for other purposes.
S.646Stabilize Medicaid and CHIP Act- provide for 12-month continuous enrollment under Medicaid and the Children's Health Insurance Program, and for other purposes.
S.908Medicare Drug Price Negotiation Act - provide for thenegotiationof lower covered part Ddrugprices on behalf ofMedicarebeneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services underMedicarepart D, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR1319American Rescue Plan ActTo provide for reconciliation pursuant to title II of S. Con. Res. 5.
Equip states, territories, and localities with sufficient financial support to combat the crisis and appropriately manage budget shortfalls driven by the economic downturn.
Lowering the cost of health care for people who purchase Marketplace plans in two key ways:
Expanding and increasing the value of advanced premium tax credits (APTCs) to reduce or eliminate health insurance premiums, ensuring no one pays more than 8.5 percent of their income for coverage.
Providing maximal APTCs to unemployment insurance (UI) recipients for the length of the public health and economic crisis. >
Enacting 100% premium subsidies for Consolidated Omnibus Budget Reconciliation Act (COBRA) continuation health coverage subsidies for people who lost their jobs during the crisis. >
Allowing Medicaid to cover care related to COVID-19 for uninsured individuals in need of treatment. >
Providing at least $600 million for intensive consumer assistance, including dedicated staff and application assistance, that builds upon the existing navigator program to help laid-off workers and their families obtain health coverage.
Extending an enhanced Medicaid federal medical assistance percentage (FMAP) rate for the length of the economic downturn -
ideally no less than 14% - alongside a robust maintenance of effort (MOE) requirement that ensures families who rely on Medicaid for their health care can keep their coverage and benefits. >
Creating a countercyclical FMAP payment mechanism that automatically increases federal contributions when state economic conditions decline and both workers and the economy need extra help.
Bolstering the Centers for Disease Control and Prevention (CDC) and investing in farreaching and equitable access to testing, contact tracing, and vaccination, including mandatory coverage of testing and approved vaccines without cost sharing in all markets and systems. >
Investing in our public health workforce while building long-term public health capacity within communities by recruiting, training, and employing community members in a workforce to assist with COVID-19 tracing, testing, and vaccinations, as well as enrolling people who have lost insurance in coverage
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.187/HR728Pandemic Emergency Manufacturing Act of 2021To amend the Public Health ServiceActto establish anEmergencyOffice ofManufacturingfor Public Health, and for other purposes.
S.909Prescription Drug Price Relief ActA bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
S.902Affordable and Safe Prescription Drug Importation ActA bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301234920.xml
Lobbying Issues
H.R 133Consolidated Appropriations Act, 2021FY 2021 funding, additional support for the COVID-19 pandemic, end to surprise billing
S3606HealthForceand ResilienceForceAct of 2020To provide for the establishment of aHealthForceand a ResilienceForceto respond to publichealthemergencies and meet publichealthneeds.
H.R. 6800HEROES ActLegislation repsonding to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pandemic response/stimulus legislationLegislation to provide consumer assistance for health coverage enrollment; to broaden premium tax credits and fully subsidizing COBRA coverage offered to laid-off workers; to expand the recently-enacted Medicaid option to support states ability to finance and expand Medicaid, including COVID 19 treatment, with eligibility extended to all in need, regardless of geography or immigration status.
H.R. 6800 - HEROES ActLegislation responding to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.
Legislation to provide a significant increase in federal matching rates for Medicaid and to maintain maintenance of effort provisions; and flexible funding for states, territories, and localities to offset major revenue losses and cost increases triggered by recession.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2021 Appropriations - Legislation to provide funding for consumer enrollment assisters and Navigators
H.R 133Consolidated Appropriations Act, 2021FY 2021 funding, additional support for the COVID-19 pandemic, end to surprise billing
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2020.
Original Filing: 301218790.xml
Lobbying Issues
H.R 8061 Community Immunity during COVID-19 Act of 2020To amend the Public Health Service Act to direct the Secretary of Health and Human Services to make grants to covered health departments to increase the rate of recommended immunizations, and for other purposes.
S. 4248COVID-19 Bias and Anti-Racism Training Act - Improving bias training in states/localities
S. 4262The COVID-19 Health Disparities Action Act- This bill establishes a series of requirements relating tothequality of care provided in nursing and long-term care facilities, specifically with respect toCOVID-19(i.e., coronavirus disease 2019) and elder abuse, and also modifies and extends several elder justice programs and initiatives.
S.4533The Anti-Racism in Public Health Act- To amendthePublicHealthServiceActto provide forpublichealthresearch andinvestmentinto understanding and eliminating structural racism and police violence.
S. 4339Masks for All Act of 2020- This bill provides fundingforthe Federal Emergency Management Agency (FEMA) to provideforthe manufacture and distribution of high-quality facemasksforevery individual in the United States during the COVID-19 (i.e., coronavirus disease 2019) emergency.
H.R.8436 - Equal Health Care for All ActTo prohibit discrimination in health care and require the provision of equitable health care,
s.4521Health Care Improvement Act- To amend the Patient Protection and AffordableCareActto reducehealthcarecosts and expandhealthcarecoverage to more Americans.
H.Res.1125- Diversity in Clinical Trials - Expressing support for prioritizing racial and ethnicdiversityinclinicaltrialsfor therapies, diagnostics, and vaccines for COVID-19.
H.R8200Ending Health Disparities During COVID-19 ActTo improve the health of minority individuals during the COVID-19 pandemic, and for other purposes
S. 4557COVid Enrollment Response (COVER) Act - To support efforts to provide intensive, individualized assistance for enrolling in health care coverage.
S.4526Coronavirus Language Access ActTo ensure that COVID-19-related Federal programs and assistance provide for the translation of informational materials relating to awareness, screening, testing, and treatment for COVID-19 into priority languages.
S.4539Taxpayer Research and Coronavirus Knowledge Act of 2020To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development related to COVID-19, and for other purposes.
H.R.8544 - STRONG Support for Children ActTo amend the Public Health Service Act to support the development and implementation of programs using data analysis to identify and facilitate strategies to improve outcomes for children in geographic areas with a high prevalence of trauma from exposure to adverse childhood experiences, and for other purposes.
H.R. 2694- the Pregnant Workers Fairness Act - prohibits employment practices that discriminate against making reasonable accommodations for qualified employees affected by pregnancy, childbirth, or related medical conditions. A qualified employee is an employee or applicant who, with or without reasonable accommodation, can perform the essential functions of the position, with specified exceptions.
S.3606Health Force and Resilience Force Act of 2020establishment of aHealthForceandaResilienceForceto respond to publichealthemergenciesandmeet publichealthneeds.
H.R. 6437/S.3609 - Coronavirus Immigrant Families Protection Actensure that all communities have access to urgently needed COVID-19 testing, treatment, public health information, and relief benefits regardless of immigration status or limited English proficiency,
H.R.8573 - To prohibit group health plans, health insurance issuers offering group or individual health insurance coverage, State plans under title XIX of the Social Security Act, State child health plans under title XXI of such Act, and the TRICARE program from applying a deductible to outpatient pediatric services.
S.4737Community Immunity during COVID-19 Act of 2020A bill to amend the Public Health Service Act to direct the Secretary of Health and Human Services to make grants to covered health departments to increase the rate of recommended immunizations, and for other purposes.
H.R.6637- HealthEquityandAccountabilityActof2020HealthEquityandAccountabilityActof2020
H.R. 7510 - AHEAD: Assimilating Health and Equity Assessments into Decision Making Act Requires Health Impact Assessments for non-health legislative proposals
Legislation to waive cost-sharing for treatments and future vaccines against SARS-CoV-2, the virus that causes COVID-19, in the next coronavirus economic stimulus bill.
Health Care and HousingLegislation to incentivize low-income housing developments that focus on social determinants of health.
H.Res.1057- Mental Health Bill Resolution expressing the sense of the House of Representatives that in order to effectively address the high prevalence of those suffering from mental health conditions and substance use disorders, the United States needs to make historic financial investments into mental health and substance use disorder care and finally acknowledge such care as a priority in health care equal to physical health
Legislation to provide a comprehensive effort to test, trace and quarantine individuals must be nationally coordinated and implemented in states and localities across the country
Pandemic response/stimulus legislationLegislation to provide consumer assistance for health coverage enrollment; to broaden premium tax credits and fully subsidizing COBRA coverage offered to laid-off workers; to expand the recently-enacted Medicaid option to support states ability to finance and expand Medicaid, including COVID 19 treatment, with eligibility extended to all in need, regardless of geography or immigration status.
H.R. 6800 - HEROES Act -Legislation responding to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pandemic response/stimulus legislationLegislation to provide consumer assistance for health coverage enrollment; to broaden premium tax credits and fully subsidizing COBRA coverage offered to laid-off workers; to expand the recently-enacted Medicaid option to support states ability to finance and expand Medicaid, including COVID 19 treatment, with eligibility extended to all in need, regardless of geography or immigration status.
H.R. 6800 - HEROES ActLegislation responding to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.
H.R.8546 - Fair Drug Prices for Kids Act - To amend titles XIX and XXI of the Social Security Act to give States the option to extend the Medicaid drug rebate program to the Children's Health Insurance Program, and for other purposes.
H.R. 7078 - EDOT Act - To study the effects of changes to telehealth under the Medicare and Medicaid programs during the COVID-19 emergency.
Legislation to provide a significant increase in federal matching rates for Medicaid and to maintain maintenance of effort provisions; and flexible funding for states, territories, and localities to offset major revenue losses and cost increases triggered by recession.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2021 Appropriations - Legislation to provide funding for consumer enrollment assisters and Navigators
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 20, 2020.
Original Filing: 301201056.xml
Lobbying Issues
S3847A bill to amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
HR6800Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES ActThis bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.
HR6561Improving Social Determinants of Health Act of 2020To authorize the Director of the Centers for Disease Control and Prevention to carry out a Social Determinants of Health Program, and for other purposes.
S3595Ensuring Understanding of COVID-19 to Protect Public Health ActTo require a longitudinal study on the impact of COVID-19.
S3877A bill to establish or expand programs to improve health equity regarding COVID-19 and reduce or eliminate inequities in the prevalence and health outcomes of COVID-19To establish or expand programs to improve health equity regarding COVID-19 and reduce or eliminate inequities in the prevalence and health outcomes of COVID-19.
HR6871Coronavirus Containment Corps ActTo create a Coronavirus Containment Corps, and for other purposes.
HR7158Health Enterprise Zones Act of 2020 To provide for the designation of areas as Health Enterprise Zones to reduce health disparities and improve health outcomes in such areas, and for other purposes.
HR6808HealthForceand ResilienceForceAct of 2020To provide for the establishment of aHealthForceand a ResilienceForceto respond to publichealthemergencies and meet publichealthneeds.
S3606HealthForceand ResilienceForceAct of 2020To provide for the establishment of aHealthForceand a ResilienceForceto respond to publichealthemergencies and meet publichealthneeds.
HR6532COVID Special Enrollment Act of 2020To amend the Patient Protection and Affordable Care Act to require the Secretary of Health and Human Services to establish a special enrollment period during the COVID-19 emergency period and to carry out outreach and educational activities, and for other purposes.
HR7113To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
HR7510ASSIMILATING HEALTH AND EQUITY ASSESSMENTS INTO DECISION-MAKING ACTTo provide for a study by the National Academies of Sciences, Engineering, and Medicine on the potential benefits on population health outcomes of incorporating into the Federal legislative process tools that measure the impacts of proposed legislation (including in areas outside of health care) on health and health disparities, and for other purposes.
HR7296Make Medications Affordable by Preventing Pandemic Pricegouging Act (MMAPPP) Act of 2020To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.
HR7288Taxpayer Research and Coronavirus Knowledge Act of 2020To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development related to COVID-19, and for other purposes.
H.R.1425 - Patient Protection and Affordable Care Enhancement Act - increase premium tax credits that help low- and moderate-income consumers buy coverage from health insurance exchanges; Incentives provided for new states to expand Medicaid-which is playing an essential role in serving children, low-income adults, seniors, those who are disabled, and other vulnerable populations; Medicaid coverage extended to one year postpartum for women; protections from interruptions in coverage by providing Medicaid and Children's Health Insurance Program beneficiaries with full 12 months of coverage once enrolled; prescription drug price negotiation
Draft legislation to address health disparities during COVID-19
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR6674Medicare Crisis Program Act of 2020To ensure access to affordable, comprehensive health insurance benefits for certain uninsured individuals during the COVID-19 emergency, and to ensure adequate coverage of treatments for COVID-19 under the Medicare and Medicaid programs and under group health plans and group or individual health insurance coverage, and for other purposes.
HR6649Lower Drug Costs for Seniors During COVID-19To amend title XVIII of the Social Security Act to provide for cost-spreading for certain fills and refills of drugs under part D of the Medicare program during the COVID-19 emergency.
HR6495Insular Area Medicaid Parity ActTo amend title XI of the Social Security Act to eliminate the general Medicaid funding limitations for territories of the United States, and for other purposes.
S4108Coronavirus Medicaid response ActA bill to amend title XIX of the Social Security Act to increase Federal support to State Medicaid programs during economic downturns, and for other purposes
Legislation to increase the Medicaid federal match during the public health emergency
Legislation to preserve Medicaid maintenance of effort provisions in Families First law
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to provide funding for consumer enrollment assisters and Navigators
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 17, 2020.
Original Filing: 301170411.xml
Lobbying Issues
H.R.1897 MOMMA's Act - Federal efforts with respect to the prevention of maternal mortality
HR 6135 No More Narrow Networks Act - To amend the Patient Protection and Affordable Care Act to require Exchanges to establish network adequacy standards for qualified health plans.
HR 6142 Black Maternal Health Caucus Momnibus - To end preventable maternal mortality and severe maternal morbidity in the United States and close disparities in maternal health outcomes, and for other purposes.
No Surprises for New Moms ActTo amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to provide for certain health coverage of newborns.
HR 6080Preventing Drug Shortages ActTo amend the Federal Food, Drug, and Cosmetic Act to reduce drug shortages, and for other purposes.
HR 6317Ensuring Coverage in Public Health Emergencies Act of 2020To provide for special enrollment periods during public health emergencies, coverage of services related to public health emergencies, and for other purposes.
HR 6136Protecting Consumers from Unreasonable Rates ActTo amend the Public Health Service Act to provide protections for consumers against excessive, unjustified, or unfairly discriminatory increases in premium rates.
HR 6201Families First Coronavirus Response ActThis bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak by providing paid sick leave, tax credits, and free COVID-19 testing; expanding food assistance and unemployment benefits; and increasing Medicaid funding.
HR 748CARES Actthis bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.
HR 5230Elijah Cummings Family Asthma ActTo amend the Public Health Service Act with regard to research on asthma, and for other purposes.
HR 4548Asthma Care and Prevention in Rural Communities ActTo authorize the Director of the Centers for Disease Control and Prevention to award grants to eligible counties for the use of mobile clinics and distance learning and telemedicine to diagnose and treat children with asthma in rural areas and medically underserved communities, and for other purposes.
HR 4716Inhaler Coverage and Access Now ActThis bill provides for coverage under a high deductible health plan not requiring a deductible of inhalers for treatment of any chronic lung disease, including asthma (and any medicine or drug which is delivered through such inhalers for treatment of such diseases).
HR 2468School-Based Allergies and Asthma Management ActTo amend the Public Health Service Act to increase the preference given, in awarding certain allergies and asthma-related grants, to States that require certain public schools to have allergies and asthma management programs, and for other purposes.H.R.2113 Prescription Drug STAR Act - require drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers
S.1895 Lower Health Care Costs Act - comprehensive legislation to end surprise medical bills, reduce prescription drug prices, improve health care transparency, improve public health, improve exchange of health information
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3 Lower Drug Costs Now Act of 2019 -allowing Medicare to negotiate prescription drug prices, limiting the ability of drug companies to spike their prices overnight, ensuring that actions to address egregious prices apply to coverage beyond Medicare
S. 2543 Prescription Drug Pricing Reduction Act of 2019 - comprehensive legislation to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers
HR 6159 Kids' Access to Primary Care Act of 2020 - To amend title XIX of the Social Security Act to renew the application of the Medicare payment rate floor to primary care services furnished under the Medicaid program, and for other purposes.
H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program.
H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care.
S.22/H.R.2951 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B
H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program
H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services.
H.R. 4996 Helping Medicaid Offer Maternity Services Act of 2019 - MOMs Act - provide for a State option under the Medicaid program to provide for and extend continuous coverage for certain individual
S.1423Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Fiscal Year 2020 Appropriations -
Funding for CDC's National Asthma Control Program
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 21, 2020.
Original Filing: 301124491.xml
Lobbying Issues
H.R.1897 MOMMA's Act - Federal efforts with respect to the prevention of maternal mortality
S.340/H.R.965CREATES - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products
H.R. 938 the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 - eligibility for FDA approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval
H.R. 1499, the Protecting Consumer Access to Generic Drugs Act of 2019 - pay for delay; prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products
H.R.2113 Prescription Drug STAR Act - require drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers
H.R.2296, S.1391 FAIR Drug Pricing Act - Rx pricing transparency, require manufacturers to justify price increases
S.1531STOP Surprise Medical Bills Act - provide protections for health insurance consumers from surprise billing
H.R.861 - End Surprise Billing Act of 2019 - prevent surprise billing practices and require notification for consumers
S.1895 Lower Health Care Costs Act - comprehensive legislation to end surprise medical bills, reduce prescription drug prices, improve health care transparency, improve public health, improve exchange of health information
H.R. 3630 No Surprises Act - legislation to protect consumers from surprise medical bills, using median in network rate and an option to go to arbitration for bills above $1250.
H.R. 3502 Protecting People From Surprise Medical Bills Act - legislation to protect consumers from surprise medical bills, arbitration as payment mechanism
H.R.748, S. 684Middle Class Health Benefits Tax Repeal Act of 2019 - repeal the excise tax on high value employer-sponsored health care coverage, also known as the Cadillac Tax
H.R.2411/S.1258 Tobacco to 21 Act - prohibit the sale of tobacco products to individuals under the age of 21
H.R.2339 Reversing the Youth Tobacco Epidemic Act - legislation to curb the rise of youth tobacco use
H.R. 4548 Asthma Care and Prevention in Rural Communities Act -authorize CDC to award grants to eligible counties for the use of mobile clinics and distance learning and telemedicine to diagnose and treat children with asthma in rural areas and medically underserved communities,
H.R.4575 - Improving Provider Directories Act - require group health plans and health insurance issuers offering group or individual health insurance coverage to establish a process to address inaccurate information listed in publicly accessible provider directories of such plans and issuers
H.R.1983 Community Health Investment, Modernization, and Excellence Act of 2019 - reauthorize and extend funding for community health centers and the National Health Service Corp
H.R.5230 - Elijah E. Cummings Family Asthma Act - create programs to better educate families on asthma management and prevention, and would improve asthma research and data collection to help target asthma interventions more effectively
S.2492STANDUP Act - provide best practices on student suicide awareness and prevention training and condition
H.R.5031 Medical Innovation Act - authorize the collection of supplemental payments to increase congressional investments in medical research
S.3162 Affordable Drug Manufacturing Act - establish an Office of Drug Manufacturing.
Legislation requiring NAS to do a study on SUD treatment for minorities and underserved communities
Kids Access to Primary Care Act - expanding kids access to primary care by aligning Medicaid reimbursement rates with Medicare payments
No Surprise Bills for New Moms Act - Require all health plans and insurers to cover newborns under their mothers coverage for 14 days after birth
Legislation around gathering research around projects that work to positively alter outcomes for children at risk of experiencing ACEs
HEAA - comprehensive legislation to address health inequities and ensure that health and health care disparities elimination are prioritized
Legislation to prevent air ambulances from balance billing patients
Legislation to require health care facilities and providers to give patients a list of services received upon discharge
Legislation to reauthorize the Patient-Centered Outcomes Research Institute (PCORI)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3 Lower Drug Costs Now Act of 2019 -allowing Medicare to negotiate prescription drug prices, limiting the ability of drug companies to spike their prices overnight, ensuring that actions to address egregious prices apply to coverage beyond Medicare
S. 2543 Prescription Drug Pricing Reduction Act of 2019 - comprehensive legislation to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers
H.AR. 4663 Freedom from Price Gouging Act - require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.
S. 64 Preserve Access to Affordable Generics and Biosimilars Act - prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products
S.3092 Expanding Access to Low Cost Generics Act - Subjecting insulin to the new pathway to bring low-cost, generic insulin products to market
S.2628 - Equity in Pretrial Medicaid Coverage Act of 2019 - remove a limitation on an individual's eligibility for medical assistance under the State Medicaid plan while the individual is in custody pending disposition of charges.
H.R. 913 - CLINICAL TREAMENT Act - requires state Medicaid programs to cover routine patient costs for items and services that are provided in connection with a qualifying clinical trial regarding cancer or other life-threatening conditions
Legislation to restore Medicaid eligibility to people from the Freely Associated States who are living in the U.S. under the terms of the Compacts of Free Association (COFA).
H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program.
H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care.
S.22/H.R.2951 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B
H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program
H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services.
S.99 / H.R.448 - The Medicare Drug Price Negotiation Act - negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D
H.R.1046 / S.377 Medicare Negotiation and Competitive Licensing Act of 2019 - requiring Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program
H.R.4671 Helping Seniors Afford Health Care Act of 2019 - reduce cost-sharing, align income and resource eligibility tests, simplify enrollment, and provide for other program improvements for low-income Medicare beneficiaries.
H.R. 4996 Helping Medicaid Offer Maternity Services Act of 2019 - MOMs Act - provide for a State option under the Medicaid program to provide for and extend continuous coverage for certain individual
H.R.1329 Medicaid Reentry Act - allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release
H.R.1354 Territories Health Equity Act - make improvements to the treatment of the United States territories under the Medicare and Medicaid programs
H.R.1384, S.1129 Medicare for All Act - establishes a national health insurance program
Medicare Prescription Drug Savings and Choice Act - public option for drug coverage within Medicare Part D
HEAL for Immigrant Women and Families Act of 2019 - Removes the five year waiting period for immigrants to become eligible for Medicaid and CHIP
S.1423Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs
S.1280BENES Act - establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process
Agencies Lobbied
U.S. Senate
Lobbying Issues
Fiscal Year 2020 Appropriations -
Funding for CDC's National Asthma Control Program
Funding for CDC to conduct public health research into firearm morbidity and mortality prevention
Senate budget proposal requiring Congress to craft and then consider deficit reduction legislation under fast-track reconciliation procedures if the Congressional Budget Office (CBO) finds that the projected debt (as a percentage of gross domestic product, or GDP) exceeds Congresss earlier projection in its budget resolution.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 18, 2019.
Original Filing: 301070107.xml
Lobbying Issues
H.R. 3222 No Federal Funds for Public Charge Act of 2019 - no Federal funds may be used to carry out the proposed rule of the Department of Homeland Security entitled Inadmissibility on Public Charge Grounds
H.R.1897 MOMMA's Act - Federal efforts with respect to the prevention of maternal mortality
H.R.2115 Public Disclosure of Drug Discounts Act - legislation to provide greater transparency of discounts provided by drug manufacturers.
S.340/H.R.965CREATES - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products
H.R. 938 the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 - eligibility for FDA approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval
H.R. 1499, the Protecting Consumer Access to Generic Drugs Act of 2019 - pay for delay; prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products
H.R.2113 Prescription Drug STAR Act - require drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers,
H.R.2296, S.1391 FAIR Drug Pricing Act - Rx pricing transparency, require manufacturers to justify price increases
H.R.2376, S.1227 Prescription Pricing for the People Act - directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain
S.Res.134 - A resolution expressing the sense of the Senate that the Department of Justice should reverse its position in Texas v. United States, No. 4:18-cv-00167-O (N.D. Tex.)
H.R.1010 - To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect
H.R.1868 - Health Care Affordability Act of 2019 - reducing insurance premiums and out-of-pocket costs in the individual and small group markets, both for low-income families and those that are not eligible for tax credits
H.R.1425 State Health Care Premium Reduction Act - Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market
H.R.986 - Protecting Americans with Preexisting Conditions Act of 2019 - certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect
H.R.987Strengthening Health Care and Lowering Prescription Drug Costs Ac- requires the Department of Health and Human Services (HHS) to conduct outreach and educational activities regarding federally-facilitated exchanges (i.e., health insurance exchanges that are established and operated within states by HHS). The activities must inform potential enrollees of the availability of coverage and related financial assistance under the exchanges and must be provided in culturally and linguistically appropriate formats.
S.1556No Junk Plans Act - rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
S.1531STOP Surprise Medical Bills Act - provide protections for health insurance consumers from surprise billing
H.R.861 - End Surprise Billing Act of 2019 - prevent surprise billing practices and require notification for consumers
S.1895 Lower Health Care Costs Act - comprehensive legislation to end surprise medical bills, reduce prescription drug prices, improve health care transparency, improve public health, improve exchange of health information
H.R. 3630 No Surprises Act - legislation to protect consumers from surprise medical bills, using median in network rate and an option to go to arbitration for bills above $1250.
H.R. 3502 Protecting People From Surprise Medical Bills Act - legislation to protect consumers from surprise medical bills, arbitration as payment mechanism
H.R.748, S. 684Middle Class Health Benefits Tax Repeal Act of 2019 - repeal the excise tax on high value employer-sponsored health care coverage, also known as the Cadillac Tax
S. 1801 Affordable Medications Act - increase drug price transparency and affordability, spur innovation, and enhance competition
S.455/ H.R.987 - MORE Health Education Act - funding for Federal Exchange outreach and educational activities
H.R.3180, S. 1770 RISE (Resilience Investment, Support, and Expansion) from Trauma Act - improve the identification and support of children and families who experience trauma
S.2387 We Protect American Investment in Drugs Act - prohibits Pharmaceutical companies developing prescription drugs using federally-funded research, like NIH or CDC grants, from charging American consumers unreasonable prices for life-saving drugs
H.R.2411/S.1258 Tobacco to 21 Act - prohibit the sale of tobacco products to individuals under the age of 21
H.R.2339 Reversing the Youth Tobacco Epidemic Act - legislation to curb the rise of youth tobacco use
H.R. 4548 Asthma Care and Prevention in Rural Communities Act -authorize CDC to award grants to eligible counties for the use of mobile clinics and distance learning and telemedicine to diagnose and treat children with asthma in rural areas and medically underserved communities,
H.R.4158 CURE High Drug Prices Act - prohibit price gouging in the sale of drugs
H.R.4575 - Improving Provider Directories Act - require group health plans and health insurance issuers offering group or individual health insurance coverage to establish a process to address inaccurate information listed in publicly accessible provider directories of such plans and issuers
H.R. 4457 Chronic Condition Copay Elimination Act - require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for additional preventive care for individuals with chronic conditions without the imposition of cost sharing requirement
H.R.2374 Stop STALLING Act - enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns
H.R.1983 Community Health Investment, Modernization, and Excellence Act of 2019 - reauthorize and extend funding for community health centers and the National Health Service Corp
Legislation to prevent air ambulances from balance billing patients
Legislation to require health care facilities and providers to give patients a list of services received upon discharge
Legislation to reauthorize the Patient-Centered Outcomes Research Institute (PCORI)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3 Lower Drug Costs Now Act of 2019 -allowing Medicare to negotiate prescription drug prices, limiting the ability of drug companies to spike their prices overnight, ensuring that actions to address egregious prices apply to coverage beyond Medicare
S. 2543 Prescription Drug Pricing Reduction Act of 2019 - comprehensive legislation to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers
H.R. 3853 Personal Needs Allowance Modernization Act of 2019 - increase under the Medicaid program the minimum monthly personal needs allowance for institutionalized individuals and couples
H.R.4386 Stop the Wait Act - eliminate the Medicare and disability insurance benefits waiting periods for disabled individuals.
H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program.
H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care.
S.22/H.R.2951 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B
H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program
H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services.
S.99 / H.R.448 - The Medicare Drug Price Negotiation Act - negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D
H.R.1046 / S.377 Medicare Negotiation and Competitive Licensing Act of 2019 - requiring Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program
S.470 Medicare at 50 Act - option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare
H.R.1329 Medicaid Reentry Act - allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release
H.R.1354 Territories Health Equity Act - make improvements to the treatment of the United States territories under the Medicare and Medicaid programs
H.R.1384, S.1129 Medicare for All Act - establishes a national health insurance program
Medicare Prescription Drug Savings and Choice Act - public option for drug coverage within Medicare Part D
HEAL for Immigrant Women and Families Act of 2019 - Removes the five year waiting period for immigrants to become eligible for Medicaid and CHIP
H.R.2463, S.1261 Choose Medicare Act - establishment of Medicare part E public health plans
S.1423Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Fiscal Year 2020 Appropriations -
Funding for CDC's National Asthma Control Program
Funding for CDC to conduct public health research into firearm morbidity and mortality prevention
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1236 the Extreme Risk Protection Order Act of 2019 - authorize the issuance of an extreme risk protection order by a federal court when law enforcement, family members, or household members seek one; support State, Tribal, and local efforts to remove access to firearms from individuals who are a danger to themselves
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 19, 2019.
Original Filing: 301051425.xml
Lobbying Issues
H.R.1897 MOMMA's Act - Federal efforts with respect to the prevention of maternal mortality
H.R.2115 Public Disclosure of Drug Discounts Act - legislation to provide greater transparency of discounts provided by drug manufacturers.
S.340/H.R.965 CREATES - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products
H.R. 938 the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 - eligibility for FDA approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval
H.R. 1520, the Purple Book Continuity Act of 2019; publication of a list of licensed biological products
H.R. 1503, the Orange Book Transparency Act of 2019; list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act,
H.R. 1781 Payment Commission Data Act of 2019 - provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information
H.R. 1264 Payment Commission Data Act of 2019 - provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information
H.R. 1499, the Protecting Consumer Access to Generic Drugs Act of 2019 - pay for delay; prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products
H.R.2113 Prescription Drug STAR Act - require drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers,
H.R.2296, S.1391 FAIR Drug Pricing Act - Rx pricing transparency, require manufacturers to justify price increases
H.R.2376, S.1227 Prescription Pricing for the People Act - directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain
S.Res.134 - A resolution expressing the sense of the Senate that the Department of Justice should reverse its position in Texas v. United States, No. 4:18-cv-00167-O (N.D. Tex.)
H.R.1010 - To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect
H.Res.356 - Expressing support for Designation of May as "National Asthma and Allergy Awareness Month"
H.R.1868 - Health Care Affordability Act of 2019 - reducing insurance premiums and out-of-pocket costs in the individual and small group markets, both for low-income families and those that are not eligible for tax credits
H.R.1385 State Allowance for a Variety of Exchanges (SAVE) Act - preserve the option of States to implement health care marketplaces
H.R.1386 ENROLL Act - amending ACA with new Navigator program requirements
H.R.1425 State Health Care Premium Reduction Act - Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market
S.1213 Consumer Health Insurance Protection Act - - comprehensive insurance reform proposals including provisions pegging consumer assistance to plans with higher actuarial value, lowering out-of-pocket maximums, extending eligibility for subsidies, fixing family glitch, investing in enrollment outreach, requiring insurers to cover emergency services at in-network costs, making short-term limited duration plans subject to ACAs consumer protections
H.R.986 - Protecting Americans with Preexisting Conditions Act of 2019 - certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect
H.R.2569, S.1365 Comprehensive Addiction Resources Emergency Act of 2019 - provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families
H.R.987 Strengthening Health Care and Lowering Prescription Drug Costs Ac- requires the Department of Health and Human Services (HHS) to conduct outreach and educational activities regarding federally-facilitated exchanges (i.e., health insurance exchanges that are established and operated within states by HHS). The activities must inform potential enrollees of the availability of coverage and related financial assistance under the exchanges and must be provided in culturally and linguistically appropriate formats.
S.1556 No Junk Plans Act - rule entitled Short-Term, Limited Duration Insurance shall have no force or effect.
S.1531 STOP Surprise Medical Bills Act - provide protections for health insurance consumers from surprise billing
H.R.861 - End Surprise Billing Act of 2019 - prevent surprise billing practices and require notification for consumers
Lower Health Care Costs Act - comprehensive legislation to end surprise medical bills, reduce prescription drug prices, improve health care transparency, improve public health, improve exchange of health information
No Surprises Act - legislation to protect consumers from surprise medical bills
Protecting People From Surprise Medical Bills Act - legislation to protect consumers from surprise medical bills, arbitration as payment mechanism
H.R.2075,S.1013 School-Based Health Center Reauthorization Act - reauthorize school-based health centers
S.1737 Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits
H.R.748, S. 684 Middle Class Health Benefits Tax Repeal Act of 2019 - repeal the excise tax on high value employer-sponsored health care coverage, also known as the Cadillac Tax
S.1935 Family Coverage Act - fix ACAs family glitch
S. 1801 Affordable Medications Act - increase drug price transparency and affordability, spur innovation, and enhance competition
S.455/ H.R.987 - MORE Health Education Act - funding for Federal Exchange outreach and educational activities
H.R.3180, S. 1770 RISE (Resilience Investment, Support, and Expansion) from Trauma Act - improve the identification and support of children and families who experience trauma
Draft legislation on patent evergreening
Legislation to reauthorize the Patient-Centered Outcomes Research Institute (PCORI)
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2757 Creating Lower Cost Alternative for Your (CLAY) Prescription Drug Act - would eliminate cost-sharing for generic drugs for low-income Medicare beneficiaries
H.R.1393 Medicare Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare program.
H.R.576 Seniors Have Eyes, Ears, and Teeth Act - expands Medicare coverage to include eyeglasses, hearing aids, and dental care.
S.22 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B
H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program
H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services.
S.99 / H.R.448 - The Medicare Drug Price Negotiation Act - negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D
H.R.1046 / S.377 Medicare Negotiation and Competitive Licensing Act of 2019 - requiring Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program
S.470 Medicare at 50 Act - option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare
H.R.1329 Medicaid Reentry Act - allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release
H.R.1354 Territories Health Equity Act - make improvements to the treatment of the United States territories under the Medicare and Medicaid programs
H.R.3215, S.1754 The Disaster Relief Medicaid Act - provide Medicaid assistance to individuals and families affected by a disaster or emergency
H.R.1384, S.1129 Medicare for All Act - establishes a national health insurance program
H.R.2477, S.1280 Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act - establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process
Medicare Prescription Drug Savings and Choice Act - public option for drug coverage within Medicare Part D
H.R.2463, S.1261 Choose Medicare Act - establishment of Medicare part E public health plans
S.1423 Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 - provide for coverage of dental, vision, and hearing care under the Medicare and Medicaid programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Fiscal Year 2020 Appropriations -
increase federal funding for the Child Abuse Prevention and Treatment Act (CAPTA)
provision to block any attempt to eliminate or limit Medicaid NEMT services.
Funding for Centers for Disease Control and Preventions (CDC) Racial and Ethnic Approaches to Community Health (REACH) program
Funding for CDC's National Asthma Control Program
Funding for CDC to conduct public health research into firearm morbidity and mortality prevention
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 12, 2019.
Original Filing: 301024591.xml
Lobbying Issues
S.102/H.R. 465 Prescription Drug Price Relief Act - oversight and disclosure requirements relating to the prices of brand-name drugs
S.97 / H.R. 447The Affordable and Safe Prescription Drug Importation Act - allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individual
Surprise billing - draft legislation to ban surprise medical billing of patients
H.R.861 - End Surprise Billing Act of 2019 - prevent surprise billing practices and require notification for consumers
S.366/H.R.1188- Forcing Limits on Abusive and Tumultuous (FLAT) Prices Act - shorten monopoly periods for prescription drugs that are the subjects of sudden price hikes
H.R.2061 - To facilitate the efforts of States to establish auto-enrollment systems to enroll certain individuals in health insurance coverage, and for other purposes.
Patient Affordability Value and Efficiency Act - exemptions to existing requirements around the ability of insurers, hospitals and clinics to pay for prescription drugs or medical devices based upon their proven effectiveness
S.455/ H.R.987 - MORE Health Education Act - funding for Federal Exchange outreach and educational activities
H.R.1010 - To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect
H.R.1385 - preserve the option of States to implement health care marketplaces,
H.R.1386 - provide for additional requirements with respect to the navigator program,
H.R.1425- Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market
H.R.986 - Protecting Americans with Preexisting Conditions Act of 2019 - certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect
H.R.1143 Educating Consumers on the Risks of Short-Term Plans Act of 2019 - provision requiring health insurance issuer offering short-term limited duration insurance to include a standardized disclosure and certain information with respect to coverage exclusions and premium variations in marketing, application, and enrollment materials distributed in connection with such insurance and prohibiting the sale of such insurance during certain periods
S.637 CURE High Drug Prices Act - prohibit price gouging in the sale of drugs
Consumer Health Insurance Protection Act - comprehensive insurance reform proposals including provisions pegging consumer assistance to plans with higher actuarial value, lowering out-of-pocket maximums, extending eligibility for subsidies, fixing family glitch, investing in enrollment outreach, requiring insurers to cover emergency services at in-network costs, making short-term limited duration plans subject to ACAs consumer protections
H.R.1897 MOMMA's Act - Federal efforts with respect to the prevention of maternal mortality
Protecting Pre-existing Conditions & Making Health Care More Affordable Act of 2019 - provisions including raising advance premium tax credits (APTCs), financing outreach and enrollment assistance, fixing family glitch, and stopping proposed regulations relating to short-term plans
Improving Health Insurance Affordability Act - increase the value of the tax credits available to people with income between 100 and 400 percent of FPL who are already eligible for assistance, while expanding eligibility for premium tax credits to include individuals with income between 400 and 800 percent of FPL
S.340/H.R.965CREATES - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products
H.R. 938 the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 - eligibility for FDA approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval
H.R. 1520, the Purple Book Continuity Act of 2019; publication of a list of licensed biological products
H.R. 1503, the Orange Book Transparency Act of 2019; list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act,
H.R. 1499, the Protecting Consumer Access to Generic Drugs Act of 2019 - pay for delay; prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislation to enhance Medigap consumer protections
S.99 / H.R.448 - The Medicare Drug Price Negotiation Act - negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D
H.R.1046 / S.377 Medicare Negotiation and Competitive Licensing Act of 2019 - requiring Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program
S.22 Medicare Dental Benefit Act of 2019 - coverage of dental services under Medicare Part B
S.470 Medicare at 50 Act - option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare
S.585SAME Act - same level of Federal matching assistance for every State that chooses to expand Medicaid coverage to newly eligible individuals, regardless of when such expansion takes place
H.R.1384 Medicare for All Act of 2019 - improved Medicare for All national health insurance program
Draft legislation to expand Medicare for all in United States
Medicare for America - establish a Medicare for America health program to provide for comprehensive health coverage for all Americans
S.873Stabilize Medicaid and CHIP Coverage Act of 2019 - 12-month continuous enrollment under Medicaid and the Children's Health Insurance Program
H.R. 1781 Payment Commission Data Act of 2019 - provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information
H.R. 945 - coverage of marriage and family therapist services and mental health counselor services under Medicare
H.R.1342 EMPOWER Care Act - reauthorize the Money Follows the Person Demonstration Program
H.R. 1343 - Protecting Married Seniors Act - provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services.
S. 18 - SAFE Hospitals Act - Legislation to reform the Medicaid DSH program
Agencies Lobbied
U.S. Senate
Lobbying Issues
United States-Mexico-Canada Agreement, or USMCA - provisions to expand prescription drug monopoly protections, thwart competition and thus undermine efforts to expand access to affordable medicines
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Fiscal Year 2019 Appropriations - continuing resolution to end the government shutdown
Fiscal Year 2020 Appropriations -
Increase the 302(b) allocations for the Labor-Health and Human Services, Agriculture, Treasury, Housing and Urban Development, Commerce, Justice and Science, and Interior, Environment and Related Agencies appropriations bills, which have jurisdiction over NDD programs serving children
Funding for CDC's National Asthma Control Program
Funding for CDC to conduct public health research into firearm morbidity and mortality prevention
Funding to help states develop plans of safe care for infants with prenatal substance exposure
Funding for Centers for Disease Control and Preventions (CDC) Racial and Ethnic Approaches to Community Health (REACH) program
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.184Gun Violence Prevention Research Act - authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2018
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 18, 2019.
Original Filing: 301009677.xml
Lobbying Issues
S.356/H.R. 1027 - Hallways to Health Act - school-based health centers
S.J.Res.63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance"
S. 3592 - No More Surprise Medical Bills Act of 2018 - protect patients with medical emergencies from surprise billing by prohibiting hospitals and providers from charging more than the in-network amount; protects patients in non-emergency situations by requiring hospitals and providers to notify patients if services will be out-of-network and get their consent
S.3775 - Affordable Drug Manufacturing Act of 2018 - public manufacturing of generic drugs in cases where the market has failed
S. 3754 - CURE High Drug Prices Act - prevent price gouging by pharmaceutical companies
S.3660 - Health Equity and Accountability Act of 2018; TITLE IV-IMPROVING HEALTH CARE ACCESS AND QUALITY - Subtitle C-Advancing Health Equity Through Payment And Delivery Reform.
H.R.2422 - Action for Dental Health Act of 2018 - reauthorize oral health promotion and disease prevention programs through FY2022
S.974 - CREATES Act of 2017 - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products
S.Res.581 - A resolution authorizing the Senate Legal Counsel to represent the Senate in Texas v. United States, No. 4:18-cv-00167-O (N.D. Tex.)
H.R.5977/S.3776 - MOMMA's Act - improve Federal efforts with respect to the prevention of maternal mortality
S.2582 - Consumer Health Insurance Protection Act- comprehensive insurance reform proposals including provisions pegging consumer assistance to plans with higher actuarial value, lowering out-of-pocket maximums, extending eligibility for subsidies, fixing family glitch, investing in enrollment outreach, requiring insurers to cover emergency services at in-network costs, making short-term limited duration plans subject to ACAs consumer protections
S.2700 - Comprehensive Addiction Resources Emergency Act of 2018 - provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families
Surprise billing - draft legislation to prevent surprise medical billing of patients.
Auto-enrollment - create a federal platform encouraging states to experiment with auto-enrollment strategies, including resources to develop necessary information-technology infrastructure
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6505 - Medicare Negotiation and Competitive Licensing Act - require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program
Oral health -Medicare dental benefit; Medicare coverage of medically necessary oral health care
S.3770 - Medicaid Drug Decisions Transparency Act - expand the scope of transparency reporting requirements related to the ownership or investment interests of health care providers and others, and to increase the penalties associated with violating such requirements
H.R. 7217 - IMPROVE Act - extend the Medicaid HCBS spousal impoverishment protections through March and reauthorize the Money Follows the Person Program with 3 months of funding
H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act - Section 5021, 5022 - H.R. 3192, the CHIP Mental Health Parity Act; Section 5031, 5032 - H.R. 4005, the Medicaid Reentry Act;
S.3462 - Improving Coverage for Substance Use Disorder Recovery Expansion Act - provide States with the option to provide medical assistance for substance use disorder treatment services to individuals; modification of IMD exclusion
H.R. 5797 - Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act - partial removal of IMD exclusion
Legislation to expand Medicare coverage
Legislation around discounts the pharmaceutical industry must provide for drugs purchased in the Medicare Part D donut hole
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.5414 - Help Separated Families Act of 2018
S.3036 - Keep Families Together Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2018.
Original Filing: 300992019.xml
Lobbying Issues
S.J.RES.63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance".
S.3411 - Affordable Medications Act - comprehensive legislation to address rising prescription drug prices
CURE High Drug Prices Act - prevent price gouging by pharmaceutical companies
S.3485 - Basic Health Program Expansion Act of 2018 - allow States to expand basic health programs to cover more low-income individuals at lower cost.
H.R.5977 - MOMMA's Act - improve Federal efforts with respect to the prevention of maternal mortality
H.R.6478 - Biosimilars Competition Act of 2018 - enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding biologic and biosimilar products
S.3194 - Capping Prescription Costs Act of 2018 - cap prescription drug cost-sharing to $250 per month for each enrolled individual, or $500 for each family starting in 2020
H.R.2889 - Closing Loopholes for Orphan Drugs Act - revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program
H.R.5942 - Health Equity and Accountability Act of 2018 - lobbied in support of entire bill; specifically lobbied in support of TITLE IV-IMPROVING HEALTH CARE ACCESS AND QUALITY - Subtitle C-Advancing Health Equity Through Payment And Delivery Reform.
H.R.2422 - Action for Dental Health Act of 2017 - HHS provides grants to improve essential oral health care for low-income and other underserved individuals by breaking down barriers to care
S.974 - CREATES Act of 2017 - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products
S.Res.581 - A resolution authorizing the Senate Legal Counsel to represent the Senate in Texas v. United States, No. 4:18-cv-00167-O (N.D. Tex.)
Reducing Costs for Out-of-Network Services Act of 2018 - cap the amount that hospitals and physicians could charge uninsured patients and out-of-network patients who have individual market coverage
Surprise billing - draft legislation to prevent surprise medical billing of patients.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.6505 - Medicare Negotiation and Competitive Licensing Act - require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program
H.R.6823 - Supporting Positive Outcomes After Release Act - suspend, rather than terminate, an individuals eligibility for medical assistance under the State Medicaid plan while such individual is an inmate of a public institution
S.3330 - Medicare and Medicaid Protection Act of 2018 - prevent legislation privatizing Medicare, limiting federal funding for Medicaid, or decreasing benefits in Medicare or Medicare in reconciliation legislation
H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act - Section 5021, 5022 - H.R. 3192, the CHIP Mental Health Parity Act; Section 5031, 5032 - H.R. 4005, the Medicaid Reentry Act;
S.3462 - Improving Coverage for Substance Use Disorder Recovery Expansion Act - provide States with the option to provide medical assistance for substance use disorder treatment services to individuals; modification of IMD exclusion
H.R. 5797 - Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act - partial removal of IMD exclusion
H.R. 3891 -clarifying the authority of State Medicaid fraud and abuse control units to investigate and prosecute cases of Medicaid patient abuse and neglect in any setting
Oral health -Medicare dental benefit; Medicare coverage of medically necessary oral health care
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.Amdt.3826 to S.Amdt.3695 - amends H.R.6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 - require HHS to submit to Congress a report on asthma control activities, include information on how states can use Medicaid funding to facilitate these activities, on public health and population level approaches to addressing environmental exposures, how health and housing can work together, and what HHS is doing to expand asthma housing and home-based related programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.5414 - Help Separated Families Act of 2018 - entire legislation
S.3036 - Keep Families Together Act - entire legislation
H.R.3440 - Dream Act of 2017 - entire legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.3357 - Anti-Corruption and Public Integrity Act - anti-corruption, lobbying reform legislation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 19, 2018.
Original Filing: 300970769.xml
Lobbying Issues
H.R.5942 - Health Equity and Accountability Act of 2018 - entire bill; specifically TITLE IV-IMPROVING HEALTH CARE ACCESS AND QUALITY - Subtitle C- Advancing Health Equity Through Payment And Delivery Reform
S.2700/H.R.5545 - Comprehensive Addiction Resources Emergency Act of 2018 - entire bill
H.R. 4 - sections 412 and 413, provides for greater transparency and consumer protection regarding air ambulance charges
H.R.2422 - Action for Dental Health Act of 2017 - entire bill
S.974 - CREATES Act of 2017 - entire bill
H.R. 3032 - Mental Health Access Improvement Act - entire bill
S. 1879 - Seniors Mental Health Access Improvement Act of 2017 - entire bill
H.R.817 - End Surprise Billing Act of 2017 - entire bill
Replacements for ACAs individual mandate - auto-enrollment proposals for the ACAs Marketplaces
340B - efforts to diminish the 340B programs ability to help serve vulnerable patients and communities
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act - Section 5021, 5022 - H.R. 3192, the CHIP Mental Health Parity Act; Section 5031, 5032 - H.R. 4005, the Medicaid Reentry Act
H.R. 5789 - entire bill; providing for Medicaid coverage protections for pregnant and post-partum women while receiving inpatient treatment for a substance use disorder
H.R. 5583 - entire bill; requiring state Medicaid programs to report on behavioral health measures that are included in CMS 2018 Core Set of Adult Health Care Quality Measures for Medicaid
H.R. 1925 - entire bill; requiring states to suspend, rather than terminate, coverage for juveniles entering incarceration, so that coverage could be immediately restarted upon release
H.R. 4998 - entire bill; allowing for former foster youth to keep Medicaid coverage up to the age of 26 regardless of whether they still live in the state where they were in foster care
H.R. 5810 - entire bill; providing additional incentives for Medicaid health homes for patients with substance use disorder
H.R.5797 - Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act - entire bill
S.3120 - HEAL Act of 2018 - Amdt Portman #2/Cardin/Brown - Medicaid Coverage for Addiction Recovery Expansion Act
H.R. 3891 - entire bill, clarifying the authority of State Medicaid fraud and abuse control units to investigate and prosecute cases of Medicaid patient abuse and neglect in any setting
Oral health - Medicare dental benefit; Medicare coverage of medically necessary oral health care
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2019 Labor-HHS-Education Appropriations - strike the Dickey Amendment and to fund research on the causes, effects, and prevention of gun violence
H.R.3 - Spending Cuts to Expired and Unnecessary Programs Act - Sec. 2 rescission of funding from Child Enrollment Contingency Fund for fiscal year 2018
H.R. 2 - Agriculture Improvement Act of 2018 -TITLE IV - NUTRITITION; cuts to Supplemental Nutrition Assistance Program
FY2018 Omnibus bill - pediatric mental health care access grants that were authorized in the 21st Century Cures Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.5414 - Help Separated Families Act of 2018 - entire legislation
S.3036 - Keep Families Together Act - entire legislation
H.R.3440 - Dream Act of 2017 - entire legislation
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 20, 2018.
Original Filing: 300954988.xml
Lobbying Issues
S.2582 - Consumer Health Insurance Protection Act- lobbied in support of entire bill; comprehensive insurance reform proposals including provisions pegging consumer assistance to plans with higher actuarial value, lowering out-of-pocket maximums, extending eligibility for subsidies, fixing family glitch, investing in enrollment outreach, requiring insurers to cover emergency services at in-network costs, making short-term limited duration plans subject to ACAs consumer protections
Amendment to S. 1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 - TITLE VI-BIPARTISAN HEALTH CARE STABILIZATION - lobbied in opposition to reinstating cost-sharing reduction (CSR) payments to insurers
S.1835 - Lower Premiums Through Reinsurance Act - lobbied in support of reinsurance
H.R.5155 - Undo Sabotage and Expand Affordability of Health Insurance Act - lobbied in support of entire bill; provisions including raising advance premium tax credits (APTCs), funding reinsurance, financing outreach and enrollment assistance, and stopping proposed regulations relating to short-term plans and association health plans (AHPs)
H.R.195 - Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes.
- DIVISION C-HEALTHY KIDS ACT - lobbied in support of long-term funding for Childrens Health Insurance Program (CHIP)
H.R.1892 - Bipartisan Budget Act
-DIVISION B-SUPPLEMENTAL APPROPRIATIONS, TAX RELIEF, AND MEDICAID CHANGES RELATING TO CERTAIN DISASTERS AND FURTHER EXTENSION OF CONTINUING APPROPRIATIONS
--SUBDIVISION 2-TAX RELIEF AND MEDICAID CHANGES RELATING TO CERTAIN DISASTERS
---TITLE III-HURRICANE MARIA RELIEF FOR PUERTO RICO AND THE VIRGIN ISLANDS MEDICAID PROGRAMS - lobbied in support of provision to fully fund Puerto Rico Medicaid for two years
-DIVISION E-HEALTH AND HUMAN SERVICES EXTENDERS
-- TITLE I-CHIP - lobbied in support of ten years of the Children's Health Insurance Plan (CHIP), increased from six years
--TITLE II-MEDICARE EXTENDERS - lobbied in support of Medicaid extenders package
--TITLE VI-CHILD AND FAMILY SERVICES AND SUPPORTS EXTENDERS - lobbied in support of MIECHV extension
--TITLE IX-PUBLIC HEALTH PROGRAMS - lobbied in support of reauthorization for Community Health Centers funding
-Lobbied for inclusion of a fix for DACA recipients
H.R.1625 - Consolidated Appropriations Act, 2018
-Lobbied in support of repealing Dickey Amendment and ending effective ban on gun violence research
-Lobbied against inclusion of CSR payments to insurers
-Lobbied for inclusion of CREATES Act
S.974 - CREATES Act - lobbied in support of entire bill; proposals to promote drug price competition by making it easier for medicines whose patents have expired to be sold as less expensive generic versions
H.R.817 - End Surprise Billing Act of 2017 - lobbied in support of policies to end the practice of balance billing for out-of-network providers
Additional issues:
Welfare reform - lobbied in opposition to legislative proposals to reform welfare, including imposing work requirements on Medicaid beneficiaries
Replacements for ACAs individual mandate - lobbied in support of auto-enrollment proposals for the ACAs Marketplaces
Oral health - lobbied in support of a Medicare dental benefit; lobbied in support of Medicare coverage of medically necessary oral health care
Health Equity and Accountability Act (HEAA) - lobbied in support of entire bill; TITLE IV - Improvement of Health Care Services - provisions to emphasize intersection of health equity and delivery system reform
Congressional Progressive Caucus FY2019 Budget - lobbied for inclusion of stabilization proposals that would stop proposed regulations relating to short-term plans and association health plans (AHPs)
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on March 8, 2018.
Original Filing: 300941128.xml
Lobbying Issues
H.R. 1 - Tax Reform Bill, Title I - Individual Tax Reform, Part VIII--Individual Mandate
Lobbied against repeal of individual mandate
H.R. 1370 - Further Additional Continuing Appropriations Act, 2018
TITLE I--PUBLIC HEALTH EXTENDERS; TITLE II--CHILDREN'S HEALTH INSURANCE PROGRAM (CHIP)
Lobbied for long-term extension of CHIP, FQHCs, and other health extenders
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Dec. 18, 2017.
Original Filing: 300920433.xml
Lobbying Issues
H.R. 1628 - American Health Care Act of 2017; Better Care Reconciliation Act of 2017
H.Res.254 - Providing for further consideration of the bill (H.R. 1628) to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017.
S.191 - Patient Freedom Act of 2017
S.222 - Obamacare Replacement Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Aug. 24, 2017.
Original Filing: 300900016.xml
Lobbying Issues
H.R. 1628 - American Health Care Act of 2017; Better Care Reconciliation Act of 2017
H.Res.254 - Providing for further consideration of the bill (H.R. 1628) to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017.
S.191 - Patient Freedom Act of 2017
S.222 - Obamacare Replacement Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Aug. 24, 2017.
Original Filing: 300900002.xml
Lobbying Issues
H.R. 1628 - American Health Care Act of 2017
S.191 - Patient Freedom Act of 2017
S.222 - Obamacare Replacement Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
Families USA Foundation, Inc. in-house lobbying effort was terminated on July 18, 2014
Original Filing: 300662507.xml
Lobbying Issues
Supported all provisions:
S.2461 - The CHIP Extension Act
The nomination of Vivek Murthy for Surgeon General
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed Certain Provisions:
H.R. 1814: Equitable Access to Care and Health (EACH) Act
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 18, 2014.
Original Filing: 300641506.xml
Lobbying Issues
Supported some provisions and opposed some provisions:
S.1871: SGR Repeal and Medicare Beneficiary Access Act of 2013
HR 2810: A bill to amend Title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians' services, and for other purposes.Supported some provisions and opposed some provisions continued:
HR 4302 Protecting Access to Medicare Act
Support all Provisions:
S. 1980 - Medicaid and CHIP Continuous Quality Act of 2014
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported All Provisions:
H.R. 4240: HEAL Immigrant Women and Families Act of 2014
Opposed Certain Provisions:
H.R. 1814: Equitable Access to Care and Health (EACH) Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed certain health provisions of H. Res 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 29, 2014.
Original Filing: 300629497.xml
Lobbying Issues
Supported some provisions and opposed some provisions:
S.1871: SGR Repeal and Medicare Beneficiary Access Act of 2013
HR 2810: A bill to amend Title XVIII of the Social Security Act to reform the sustainable growth rate and Medicare payment for physicians' services, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed all provisions:
H.R. 3350: Keep Your Health Plan Act of 2013
S 1642: Keeping the Affordable Care Act Promise Act
S. 1617: If You Like Your Health Plan, You Can Keep it ActOpposed all Provisions:
S. 1699: Continuous Coverage Act
Opposed Some Health Related Provisions:
H.J. Res. 59, Continuing Appropriations Resolution, 2014
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed provisions of and supported provisions of H.R.2642, the Federal Agriculture Reform and Risk Management Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for and against certain health provisions of H.J.Res. 59, the Bipartisan Budget Act of 2013
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 21, 2013.
Original Filing: 300605098.xml
Lobbying Issues
Supported all provisions: H.R. 1588/S. 740, The Medicare Drug Savings Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions:
H.R. 1698, the Stabilize Medicaid and CHIP Coverage ActOpposed all Provisions:
H.R.2668, Fairness for American Families Act
H.R.2667, Authority for Mandate Delay Act
Opposed Some Health Related Provisions:
H.J. Res. 59, Continuing Appropriations Resolution, 2014
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 16, 2013.
Original Filing: 300573091.xml
Lobbying Issues
Supported all provisions: H.R. 1588/S. 740, The Medicare Drug Savings Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions: S.482, The Health Insurance Rate Review Act
H.R. 1286/S. 631, The Healthy Families Act
S. Amdt 1317 to S. 744, Taxpayer Eligibility for Federal Programs
Opposed all Provisions:
H.R. 2328, Access to Professional Health Insurance Advisors Act of 2013
S. Amdt 1248 to S. 744, Application of Waiting Periods for Purposes of PPACA
H.R. 45, To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010.
H.R. 1549, the Helping Sick Americans Now Act
Supported Some Health Related Provisions and Opposed Some Health Related Provisions:
S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H. Res. 243, Providing for consideration of the bill (H.R. 2216) making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2014, and for other purposes; and providing for consideration of the bill (H.R. 2217) making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2014, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed Some Provisions: H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013
Supported All Provisions: H. Amdt. 176 to H.R. 1947, Amendment sought to restore the $20.5 billion cuts in SNAP by offsetting the Farm Risk Management Election Program and the Supplemental Coverage Option.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 19, 2013.
Original Filing: 300556656.xml
Lobbying Issues
Supported all provisions: S.AMDT.432 to S.CON.RES.8, To establish a deficit-neutral reserve fund to protect Medicare's guaranteed benefits and to prohibit replacing guaranteed benefits with the House passed budget plan to turn Medicare into a voucher program.
S. 569/H.R. 1179, the Improving Access to Medicare Coverage Act of 2013.
H.R.912: Restoring Medicaid for Compact of Free Association Migrants Act of 2013Opposed all provisions: S.Amdt. 297 to S.Con.Res. 8, To promote innovation, preserve high-paying jobs, and encourage economic growth for manufacturers of lifesaving medical devices and cutting edge medical therapies.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions: S. 504,Fair And Immediate Release of Generic Drugs Act
Opposed all provisions: H. R. 544, Letting Insurance Benefit Everyone Regardless of Their Youth (LIBERTY) Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed all provisions: H.Con.Res. 25, the FY 2014 House Budget Resolution
Supported some provisions: S.Con.Res. 8, the FY 2014 Senate Budget Resolution
Opposed some provisions and supported some provisions: H.R. 8, The American Taxpayer Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 22, 2013.
Original Filing: 300538323.xml
Lobbying Issues
Opposed all positions:
H.R. 1206: The Access to Professional Health Insurance Advisors Act of 2011
S. 2288: The Access to Independent Health Insurance Advisors Act of 2012Opposed all provisions:
H.R.436: Health Care Cost Reduction Act of 2012
S. 17: Medical Device Access and Innovation Protection Act
H.R. 6684: Spending Reduction Act of 2012
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 11, 2012.
Original Filing: 300505089.xml
Lobbying Issues
Supported all provisions:
S.3289, Children's Mental Health Accessibility Act of 2012
2nd Quarter, 2012
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 19, 2012.
Original Filing: 300489907.xml
Lobbying Issues
Supported all provisions:
S. 1878/H.R. 4091, Coordination of Pro Bono Medically Recommended Dental Care Act
H.R. 4254, Medicare Advantage Program Integrity Act of 2012
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions:
S. 2474, Health Equity and Accountability Act
S. 3272, Comprehensive Dental Reform Act of 2012
S. 3350, End Debt Collector Abuse Act of 2012Opposed all provisions:
H.R. 436, Health Care Cost Reduction Act of 2012
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed all provisions until indicated otherwise
H.Amdt. 1076 to H.R. 5326, An amendment [to] prohibit the use of funds by the Census Bureau for enforcement of a criminal penalty imposed upon those individuals who choose not to complete the American Community Survey.
H.Amdt. 1077 to H.R. 5326, An amendment to prohibit the use of funds to conduct the survey, continued next page Opposed all provisions unless indicated otherwise
Continuation of H.Amdt. 1077 to H.R. 5326 conducted by the Secretary of Commerce, commonly referred to as the "American Community Survey".
H.R. 5652, Sequester Replacement Reconciliation Act of 2012, opposed provisions relating to ending protections for people receiving tax subsidies, ending the Medicaid Maintenance of Effort, cutting funding for the prevention fund, cutting state incentives to enroll kids in CHIP and Medicaid, ending grants to states to set up exchanges, limiting provider taxes, and cuts to Medicaid for the U.S. territories.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 19, 2012.
Original Filing: 300465243.xml
Lobbying Issues
Supported all provisions, unless indicated otherwise
H.R. 4254, Medicare Advantage Program Integrity Act of 2012
H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - supported extending the Qualified Individual (QI) program
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions: S. 1882, Fair And Immediate Release of Generic Drugs Act
Opposed all provisions: S. Amdt. 1520 to S. 1813 - To amend the Patient Protection and Affordable Care Act to protect rights of conscience with regard to requirements for coverage of specific items and servicesOpposed all provisions: H.R. 1173, Fiscal Responsibility and Retirement Security Act of 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed all provisions: H. Con. Res. 112, Establishing the budget for the United States Government for fiscal year 2013 and setting forth appropriate budgetary levels for fiscal years 2014 through 2022
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 18, 2012.
Original Filing: 300440112.xml
Lobbying Issues
Supported all provisions:
S. 31, Prescription Drug and Health Improvement Act of 2011
S. 227, H.R. 2267, Home Health Care Planning Improvement Act of 2011
S. 1206, H.R. 2190, Medicare Drug Savings Act of 2011Continuation of supported all provisions:
S.1356, H.R. 3342, The Affordable Medicines Utilization Act of 2011
S. 1416, H.R. 2645, Medigap Medical Loss Ratio Improvement Act of 2011
H.R. 999, Medicare Prescription Drug Savings Choice Act of 2011
Opposed all provisions:
S. 868, H.R. 1683, State Flexibility Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions: S. 984, H.R. 1876, Healthy Families Act
Opposed all provisions: S. 720, Repeal the CLASS Entitlement Act of 2011, H.R. 1173, Fiscal Responsibility and Retirement Security Act of 2011Continuation of opposed all provisions:
S. 1882, Fair and Immediate Release of Generic Drugs Act
H.R. 1206, Access to Professional Health Insurance Advisors Act of 2011
H.R. 2077, MLR Repeal Act of 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2055, Consolidated Appropriations Act of 2012 - we supported funding related to Health and Human Services Division F
Opposed all provisions:
H.R. 2560, Cut, Cap and Balance Act of 2011
H.J. Res. 2, Proposing a Balanced Budget Amendment to the Constitution of the United States
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2011.
Original Filing: 300423347.xml
Lobbying Issues
Supported all provisions: S. 1206/H.R. 2190, Medicare Drug Savings Act of 2011
S. 1416/H.R. 2645, Medigap Medical Loss Ratio Improvement Act
Opposed all provisions: S. 868/H.R. 1683, State Flexibility Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions: S. 984/H.R. 1876, Healthy Families Act
Opposed all provisions:H.R. 1206, Access to Professional Health Insurance Advisors Act of 2011
H.R. 2077, MLR Repeal Act of 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions: S. 365, Budget Control Act of 2011
H.R. 2608, Continuing Appropriations Act, FY 2012
Opposed all provisions: H.R. 2560, Cut, Cap and Balance Act of 2011
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 19, 2011.
Original Filing: 300394622.xml
Lobbying Issues
Supported all provisions: S. 818/H.R. 1543, Improving Access to Medicare Coverage Act of 2011
S. 1206/H.R. 2190, Medicare Drug Savings Act of 2011
Opposed all provisions: H.R. 1683, State Flexibility Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions: S. 1088, Retiree Health Coverage Protection Act
S. 1283/H.R. 2364, Family and Medical [Leave] Inclusion Act
H.R. 3090 (111th Congress bill number), Health Equity and Accountability Act of 2009
S. 1273/H.R. 2341, Direct Care Job Quality Improvement ActOpposed all provisions:
H.R. 1213, To repeal mandatory funding provided to States in the Patient Protection and Affordable Care Ac to establish American Health Benefit Exchanges
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed all provisions:
FY 2012 House Budget Resolution
H.J. Res. 1, Proposing a Balanced Budget Amendment to the Constitution of the United States
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 19, 2011.
Original Filing: 300369077.xml
Lobbying Issues
Supported all provisions:
S. 31, Prescription Drug and Health Improvement Act of 2011
H.R. 999 and S. 560, Medicare Prescription Drug Savings and Choice Act of 2011
S. 374, Medicare Mental Health Inpatient Equity Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Opposed all provisions:
H.R. 2, Repealing the Job-Killing Health Care Act
H.R. 10, Regulations from the Executive in Need of Scrutiny Act of 2011
H.R. 358, Sanctity of Life ActOpposed all provisions:
H.R. 4, The Small Business Paperwork Mandate Elimination Act of 2011
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Oppose all provisions:
H.R. 1, Full-Year Continuing Appropriations Act, 2011
H.R. 3, No Taxpayer Funding for Abortion Act
House Appropriations Committee Bill for FY 2011 Continuing Resolution, particularly cut in Title X family planning program
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2011.
Original Filing: 300343127.xml
Lobbying Issues
H.R. 4994, Medicare and Medicaid Extenders Act of 2010, supported the one-year extension of Transitional Medicaid Assistance but opposed the offset, which helped pay for a one-year extension of Medicare reimbursements to physicians but weakened the safe harbor provision in the Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported S. Admt. 4713, which would have repealed the Form 1099 rules for business in the Affordable Care Act.
3rd Quarter, 2010
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2010.
Original Filing: 300317266.xml
Lobbying Issues
Supported all provisions, unless indicated otherwise:
S. Amdt. 4519 to H.R. 5297, Small Business Jobs and Credit Act of 2010 - oppose repreal of 1099 reporting requirement and elimination of prevention funds
S. Amdt. 4595 to H.R., 5297, Small Business Jobs and Credit Act of 2010Supported all provisions unless indicated otherwise:
S. Jt. Res. 39, Disapproval of Grandfathered Health Plans - opposed all provisions
Lobbying Issues
Supported all provisions unless indicated otherwise:
H.R. 1586, Education Jobs and Medicaid Assistance (originally FAA Air Transportation Modernization and Safety Improvement Act) - supported FMAP extension and opposed reduction in SNAP benefits
H.R. 4213, American Jobs, Closing Tax Loopholes and Preventing Outsourcing Act - supported FMAP extensionSupported all provisions unless indicated otherwise:
H.R. 5712, Veterans', Seniors', and Children's Health Technical Corrections Act of 2010
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300295660.xml
Lobbying Issues
Supported all provisions, unless indicated otherwise:
H.R. 4757/S.3078, Health Insurance Rate Authority Act of 2010
H.R. 3421, Medical Debt Relief Act of 2009
H.R. 4700, Transparency in All Health Care Pricing Act of 2010Supported all provisions, unless indicated otherwise:
S. Res. 553, Seniors' Bill of Rights
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions, unless indicated otherwise:
H.R. 4213 and numerous versions, American Jobs and Closing Tax Loopholes Act of 2010 - supported FMAP extension,
COBRA subsidy extension and physician payment fix
S. Amdt. 4361 to H.R. 4213 - supported returning lost savings in pay-for-delay settlements to consumersSupported all provisions, unless indicated otherwise:
Real Enforcement with Practical Answers for Immigration Reform (REPAIR) proposal - no bill number yet -
supported provisions to provide legal immigrants with earlier access to Medicaid and CHIP
Supported nomination of Dr. Donald Berwick to be Administrator of CMS
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 19, 2010.
Original Filing: 300263180.xml
Lobbying Issues
Supported all provisions, unless otherwise indicated:
H.R. 3590 Patient Protection and Affordable Care Act
H.R. 4691, Temporary Extension Act of 2010, provisions relating to extension of COBRA subsidy
H.R. 4851, The Continuing Extension Act of 2010, provisions relating to extension of COBRA subsidyH.R. 4872, Health Care and Education Reconciliation Act of 2010, health care provisions only
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4213, Tax Extenders Act of 2009, supported extension of the FMAP increase for an additional six months
Lobbying Issues
FY 2011 Labor, Health and Human Services, and Education Appropriations bill - support for funding programs that assist beneficiaries in accessing and navigating Medicare Part D prescription drug benefits
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300240393.xml
Lobbying Issues
Supported all provisions unless otherwise indicated:
H.R. 3200, America's Affordable Health Choices Act of 2009
H.R. 3930, Extended COBRA Continuation Protection Act of 2009
H.R. 3962, Affordable Health Care for America Act - in addition to supporting bill, in particular supported increasing MedicaidSupported all provisions unless otherwise indicated:
Continuation of H.R. 3962 from page 2: eligibility to 150 percent of the federal poverty level
H.R. 3966, To amend the American Reinvestment and Recovery Act of 2009 to extend for 6 months the period of eligibility for COBRA premium assistance under such Act.
Senate Finance Committee Chairman's Mark, America's Healthy Future Act - in addition to supporting Mark, in particular supported subsidy cap at two percent for low-income people.
S. 1730, Fairness in Health Insurance Act
S. 2730, COBRA Subsidy Extension and Enhancement Act of 2009
H.R. 3590, in the Senate, Patient Protection and Affordable Care Act - in addition to supporting bill, specifically opposed Section 1333 relating to Health Care Choice Compacts and "nationwide plan" and opposed Section 2705 relating to wellness provisions.
In addition to supporting H.R. 3590, in particular supported provisions for low-income people: increasing Medicaid eligibility to 150 percent of the federal poverty level; offering stronger premium subsidies for people below 250 percent of the federal povery level; reducing high deductibles and high copayments and improving out-of-pocket limits for low-income people; and also supported closing the doughnut hole for Medicare beneficiaries. Also supported Subtitle D physician payments sunshine provision.
Supported the following amendments to H.R. 3590: S.Amdt. 2790 (improve CHIP), S.Amdt. 2868 (include language services and cultural competency training in market-based incentives provision), S.Amdt. 2910 (require 90% minimum loss ratios for health insurance coverage), S.Amdt. 2919 (add external appeals process), S.Amdt. 2920 (insurance company reporting requirements regarding the rate of denial of coverage and enrollment), S.Amdt. 2991 (lift five-year ban on Medicaid for legal immigrant adults), S.Amdt. 3004 (price transparency), S.Amdt. 3065 (make good the provisions of the 2001 Patients' Bill of rights that both House and Senate passed but weren't signed into law), S.Amdt. 3076 (extend cessation benefits to all Medicaid recipients), S.Amdt. 3086 (provide incentives to states to offer home and community-based services as long-term care alternatives to nursing homes), and S.Amdt. 3167 (streamline enrollment).
Opposed the following amendment to H.R. 3590: S.Amdt. 3189 (provisions related to Medicare and health behaviors).
.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense appropriations bill - supported extending COBRA subsidy for 15 months to those losing jobs through 2/28/10.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 14, 2009.
Original Filing: 300204663.xml
Lobbying Issues
Supported all provisions unless indicated otherwise:
S. 958, MediKids Health Insurance Act
S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009
S.726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines ActSupported all provisions unless indicated otherwise:
H.R. 1407, Medicare Part D Home and Community Services Copayment Equity Act of 2009
H.R. 2496, Children's Health Insurance Accessibility Act of 2009
H.R. 2700, Prescription Coverage Now Act of 2009
H.R. 2716, Medicare Savings Program Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless indicated otherwise:
S. 683, Community Choice Act of 2009
S. 1679, Affordable Health Care Choices Act
S.979/H.R. 2360, Small Business Health Options Program (SHOP) Act of 2009Supported all provisions unless indicated otherwise:
Senate Finance Committee White Paper Expanding Health Care Coverage: Proposals to Provide Affordable Coverage - supported/recommended provisions to end two-year wait for Medicare; expand Medicaid; provide adequate benefits packages for low- and moderate-income people; include caps on out-of-pocket costs; protect low-income Medicare beneficiaries; and address health disparities
No bill number, Senate Finance Committee's America's Healthy Future Act:supported/recommended provisions to improve/include consumer protections; include caps on out-of-pocket costs; include limits on premium costs; provide adequate benefits for low- and moderate-income people; protect low-income Medicare beneficiaries; align Medicaid coverage with subsidies; increase subsidies and make coverage affordable for low- and moderate-income families; end age rating and prohibit workplace wellness; support provisions regarding increasing drug rebate; and include EPSDT for children
S. 1142, Informed Health Care Decision-Making Act
S. Con. Res. 32, A bill expressing the Sense of Congress on health care reform legislation
S. 697/H.R. 1721, Community Living Assistance Services and Supports Act or CLASS Act
S. 1050/H.R. 2427, Informed Consumer Choices in Health Care Act of 2009
S. 1152/H.R. 2460, Healthy Families Act
H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
H.R. 2427, Informed Consumer Choices in Health Care Act of 2009
H.R. 2744, Equal Rights for Helath Care Act - Title 42
H.R. 3090, Health Equity and Accountability Act of 2009
H.R. 3200, America's Affordable Health Choices Act of 2009
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300187634.xml
Lobbying Issues
Supported all provisions unless indicated otherwise:
S. 958, MediKids Health Insurance Act
S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009
Supported all provisions unless indicated otherwise:
Senate Finance Committee White Paper Expanding Health Care Coverage: Proposals to Provide Affordable Coverage - supported/recommended provision to end two-year wait for Medicare; expand Medicaid; provide adequate benefits packages for low- and moderate-income people; include caps on out-of-pocket costs; protect low-income Medicare beneficiaries; and address health disparities
S.726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act
H.R. 1407, Medicare Part D Home and Community Services Copayment Equity Act of 2009
H.R. 2496, Children's Health Insurance Accessibility Act of 2009
H.R. 2700, Prescription Coverage Now Act of 2009
H.R. 2716, Medicare Savings Program Improvement Act of 2009
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless indicated otherwise:
no bill number, Affordable Health Choices Act in Senate HELP Committee
S. 683, Community Choice Act of 2009
S. 979/H.R. 2360, Small Business Health Options Program (SHOP) Act of 2009Supported all provisions unless indicated otherwise:
S. 1142, Informed Health Care Decision-making Act
S. 697/H.R. 1721, Community Living Assistance Services and Supports Act or CLASS Act
S. 1050/H.R. 2427, Informed Consumer Choices in Health Care Act of 2009
S. 1152/H.R. 2460, Healthy Families Act
H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
H.R. 2744, Equal Rights for Health Care Act - Title 42
H.R. 3090, Health Equity and Accountability Act of 2009
No bill number, House TriCommittee draft of health care reform legislation
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300159469.xml
Lobbying Issues
Supported all provisions unless otherwise indicated:
S.330/H.R.684 - Medicare Prescription Drug Savings and Choice Act of 2009 - both Senate and House
S.534/H.R.1407 - Home and Community Services Copayment Equity Act of 2009/Medicare Part D Home and Community Services Copayment Equity Act of 2009 - both Senate and HouseSupported all provisions unless otherwise indicated:
H.R.2 - Children's Health Insurance Program Reauthorization Act of 2009 - both Senate and House
S.700/H.R.1708 - Ending the Medicare Disability Waiting Period Act of 2009 - both Senate and House
S.301 - Physician Payments Sunshine Act of 2009 - Senate only
H.R.1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 - House only
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
S.540/H.R.1346 - Medical Device Safety Act of 2009 - both Senate and House
S.697/H.R.1721 - CLASS Act (Community Living Assistance Services and Supports Act) - both Senate and House
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported portions dealing with health care reform
S.Con.Res.13/H.R.Con.Res.85 - Concurrent resolution setting forth the Congressional budget for the United States Government
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1/H.R.1 - The American Recovery and Reinvestment Act of 2009 - supported health care provisions related to subsidies for COBRA coverage for laid off workers; additional federal dollars for state Medicaid programs; and extending Transitional Medical Assistance - both Senate and House
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Economics/Economic Development
4th Quarter, 2008
In Q4, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300129033.xml
Lobbying Issues
Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE
S.2620, H.R. 5268, To provide a temporary increase of the Federal medical assistance percentage (FMAP) under the Medicaid program and for other purposesSupported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
S. 3101, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
S. 2102, H.R. 154, Ending the Medicare Disability Waiting Period Act of 2007
S. 3560, QI [Qualified Individuals] Program Supplemental Funding Act of 2008
H.R. 7110, Job Creation and Unemployment Relief Act of 2008 - supported provisions related to temporary FMAP increase
SENATE ONLY:
S. 2586, State Fiscal Relief Act of 2008, provisions relating to providing a temporary FMAP increase, freezing the Medicaid regulations and for other purposes
S. 2819, Economic Recovery in Health Care Act of 2008
HOUSE ONLY:
H.R. 5613, Protecting the Medicaid Safety Net Act of 2008
H.R. 6684, Medicare Prescription Drug Cost Equalization Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
S. 2795, H.R. 6210, Small Business Health Options Program (SHOP) Act
H.R. 1424, Emergency Economic Stabilization Act of 2008 - supported mental health parity provisionsSupported all provisions unless otherwise indicated:
SENATE ONLY:
S. 1576, Minority Health Improvement and Health Disparity Elimination Act
S. 2838, Fairness in Nursing Home Arbitration Act
HOUSE ONLY:
H.R. 3309, Voluntary State Discount Prescription Drug Plan Act of 2007
H.R. 6316, Climate MATTERS Act of 2008
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE
S. 3230, the Labor-HHS-Education and Related Agencies Appropriations Bill: Increased funding for CDC (global health); NIH (neglected diseases, National Institute for Allergy and Infectious Diseases and the Fogary Center); and increased funding for CMSSupported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
Continuation of S. 3230, ... operations of the State Health Insurance Assistance Programs (SHIPs)
H.R. 2638, Consolidated Security, Disaster Assistance and Continuing Appropriations Act of 2009 - supported same provisions as described above under S. 3230
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on Oct. 15, 2008.
Original Filing: 300092582.xml
Lobbying Issues
Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
S. 2620, H.R. 5268, To provide a temporary increase of the Federal medical assistance percentage (FMAP) under the Medicaid program and for other purposes Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
S. 3101, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
S. 2102, H.R. 154, Ending the Medicare Disabaility Waiting Period Act of 2007
S. 3560, QI [Qualified Individuals] Program Supplemental Funding Act of 2008
H.R. 7110, Job Creation and Unemployment Relief Act of 2008 - supported provisions related to temporary FMAP increase
SENATE ONLY:
S. 2586, State Fiscal Relief Act of 2008, provisions relating to providing a temporary FMAP increase, freezing the Medicaid regulations and for other purposes
S. 2819, Economic Recovery in Health Care Act of 2008
S.J. Res. 44, A Joint Resolution for Congressional Disapproval of the Rule Set Forth as Requirements Contained in the August 17, 2007, Letter to State Health Officials from the Director of the Center for Medicaid and State Operations ...
HOUSE ONLY:
H.R. 5613, Protecting the Medicaid Safety Net Act of 2008
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
S. 2795, H.R. 6210, Small Business Health Options Program (SHOP) Act
S. 558, H.R. 1367, Mental Health Parity Act of 2007 Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
H.R. 1424, Emergency Economic Stabilization Act, supported the mental health parity provisions.
SENATE ONLY:
S. 1576, Minority Health Improvement and Health Disparity Elimination Act
S. 2838, Fairness in Nursing Home Arbitration Act
HOUSE ONLY:
H.R. 758, Breast Cancer Patient Protection Act of 2007
H.R. 3309, Voluntary State Discount Prescription Drug Plan Act of 2007
H.R. 6316, Climate MATTERS Act of 2008
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
S. 3230, the Labor-HHS-Education and Related Agencies Appropriations Bill: Increased funding for CDC (global health); NIH (neglected diseases, National Institute for Allergy and Infectious Diseases and the Fogarty Center); and increased funding for CMS Supported all provisions unless otherwise indicated:
BOTH SENATE AND HOUSE:
Continuation of S. 3230, ... operations of the State Health Insurance Assistance Programs (SHIPS)
H.R. 2638, Consolidated Security, Disaster Assistance and Continuing Appropriations Act 2009 - supported same provisions as described above under S. 3230
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300079438.xml
Lobbying Issues
Supported all provisions unless otherwise indicated:
S. 2578, H.R. 5173, To temporarily delay application of proposed changes to Medicaid payment rules for case management and targeted case management services - both Senate and HouseSupported all provisions unless otherwise indicated:
S. 2620, H.R. 5268, To provide a temporary increase of the Federal medical assistance percentage (FMAP) under the Medicaid program and for other purposes - both Senate and House
S. 3101, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 - both Senate and House
S. 1200, Indian Health Care Improvement Act Amendments of 2008, supported Klobuchar-Coleman amendment on Medicaid regulations regarding target case management - Senate only
S. 2586, State Fiscal Relief Act of 2008, provisions relating to providing a temporary FMAP increase, freezing the Medicaid regulations and for other purposes - Senate only
S. 2819, Economic Recovery in Health Care Act of 2008 - Senate only
H.R. 5613, Protecting the Medicaid Safety Net Act of 2008 - House only
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
S. 2795, H.R. 6210, Small Business Health Options Program (SHOP) Act - Senate and House
S. 1576, Minority Health Improvement and Health Disparity Elimination Act - Senate only
H.R. 758, Breast Cancer Patient Protection Act of 2007 - House onlySupported all provisions unless otherwise indicated:
H.R. 3309, Voluntary State Discount Prescription Drug Plan Act of 2007 - House only
H.R. 6316. Climate MATTERS Act of 2008 - House only
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
The Labor-HHS-Education and Related Agencies Appropriations Bill (that will become S. 3230): Increased funding for CDC (global health); NIH (neglected diseases, National Institute for Allergy and Infectious Diseases and the Fogarty Center); and increased funding for CMS operations of the State Health Insurance Assistance Programs (SHIPs) - both Senate and HouseSupported all provisions unless otherwise indicated:
H.R. 2642, Supplemental Appropriations Act of 2008, supported freezing Medicaid regulations - Title VII - both Senate and House
H. Con. Res. 312, S. Con. Res. 70, Concurrent Resolution on the Budget for 2009: supported higher domestic discrionary funding for human services programs - both Senate and House
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, Families USA Foundation, Inc. had in-house lobbyists. The report was filed on April 21, 2008.
Original Filing: 300051359.xml
Lobbying Issues
Supported all provisions unless otherwise indicated:
S. 2578, H.R. 5173, to temporarily delay application of proposed changes to Medicaid payment rules for case management and targeted case management services - both Senate and HouseSupported all provisions unless otherwise indicated:
S. 2620, H.R. 5268, to provide a temporary increase of the federal medical assistance percentage under the Medicaid program, and for other purposes - both Senate and House
S. 1200, Indian Health Care Improvement Act Amendments of 2008, supported Klobuchar-Coleman amendment on Medicaid regulations regarding target case management - Senate only
S. 2586, State Fiscal Relief Act of 2008 - Senate only
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
S. 1760, H.R. 3267, Healthy Start Reauthorization Act of 2007 - both Senate and House
S. 1576, Minority Health Improvement and Health Disparity Elimination Act - Senate only
S. 2641, Nursing Home Transparency and Improvement Act of 2008 - Senate onlySupported all provisions unless otherwise indicated:
H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act - House only
H.R. 5449, No Discrimination in Health Insurance Act of 2008 - House only
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Supported all provisions unless otherwise indicated:
For legislation that will be the Labor-HHS-Education Appropriation bill (no bill #s yet): increased funding for: CDC (generally, National Center for Injury Prevention and Control, and global health); NIH (generally, the National Institute for Allergy and Infectious Diseases and the Fogarty Center); and CMS operations (SHIP program) - both Senate and HouseSupported all provisions unless otherwise indicated:
H. Con. Res. 312, S. Con. Res 70, Concurrent Resolution on the Budget for FY 2009: higher domestic discretionary funding for human services programs - both Senate and House
The following four amendments were only in the Senate:
Bingaman amendment on increasing funding for Medicare Savings Programs
Sanders amendment on investing in families and communities
Dodd amendment on maternal and child block grant
Grassley amendment on Medicaid regulation - opposed
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5140, Recovery Rebates and Economic Stimulus for the American People Act of 2008, title changed to Economic Stimulus Act of 2008. Supported provisions related to extending unemployment insurance, FMAP increase, and bigger stimulus for low-income workers - both Senate and House
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Economics/Economic Development
Lobbying Issues
H.R. 2419, Farm, Nutrition and Bioenergy Act of 2007, supported Title IV provisions in the House version relating to merit staffing.
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...